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Summary 
Today antibiotics are used to restrain bacterial diseases in aquaculture, however, alternative 
strategies for bacterial disease control are needed due to the risk of resistance development and 
transfer of resistance to other bacteria e.g. human pathogens. Probiotics, which are “live organisms 
which when administered in adequate amounts confer a health benefit on the host” (FAO/WHO, 
2001), can probably be used in e.g. fish larvae cultures. Phaeobacter and Ruegeria species, which 
belong to the marine Roseobacter clade, have been suggested as probiotic organisms in aquaculture. 
They inhibit or kill fish pathogenic bacteria in vitro and are capable of reducing mortality of fish 
larvae infected with fish pathogenic bacteria. It is hypothesized that this effect is caused by 
production of the secondary metabolite tropodithietic acid (TDA). 
The purpose of the present PhD study was to investigate the occurrence of antagonistic Roseobacter 
clade strains in aquaculture and to determine the growth conditions under which these strains 
produce TDA. Also, the thesis has evaluated the risk/likelihood of development of resistance and 
tolerance to TDA. 
This study showed that a Danish turbot larvae rearing unit was colonized with roseobacters that 
inhibited the fish pathogenic bacteria Vibrio anguillarum strain 90-11-287. Strains isolated from the 
production site (e.g. fish tanks) were by phenotypic tests and 16S rRNA phylogeny identified as 
Phaeobacter inhibens and Phaeobacter gallaeciensis-like, whereas strains from algae culture were 
identical to Ruegeria mobilis. Phaeobacter and Ruegeria strain have previously been shown to 
inhabit Spanish turbot larvae rearing units. These Spanish strains were phenotypically and by 16S 
rRNA gene comparisons highly similar to the Danish strains isolated in this study. Despite the very 
different water sources in the two aquaculture settings (the Galician Atlantic Ocean versus the 
Danish fjord Limfjorden) they are both colonized with an antagonistic Phaeobacter / Ruegeria 
population.  
All the Phaeobacter and Ruegeria strains isolated from the Danish turbot larvae rearing unit 
produced TDA at stagnant growth conditions and this phenotype co-occurred with the ability to 
inhibit V. anguillarum strain 90-11-287, the ability to grow in rosette-like structures and production 
of brown pigment. All the Phaeobacter strains also displayed these phenotypes when grown at 
shaking conditions, whereas this was not the case for the Ruegeria strains. The only exception from 
this pattern is strain 27-4 which is identified as Phaeobacter, but behaves like a Ruegeria.  
Many attempts were tried in order to generate TDA resistant mutants, however, no mutants were 
isolated. It is thought that TDA has multiple target sites in a bacterial cell, and that resistance 
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requires a multitude of mutations in the cell that are unlikely to co-occur. After long-term exposure 
to subinhibitory concentrations of TDA, strains with a slightly increased tolerance to TDA were 
selected, but this tolerance was abolished after one passage in media without the antimicrobial 
agent. In this thesis it is hypothesized that this transient tolerance is due to a phenotypic switch 
which can be rapidly reverted, and it can be caused by e.g. altered gene expression. 
This study showed that TDA is bactericidal against both Gram-positive and Gram-negative bacteria, 
with the Gram-positives being most susceptible. Neither efflux pumps nor porins are involved in the 
innate resistance of Gram-negative bacteria. TDA is active against both growing and non-growing 
Salmonella Typhimurium and Staphylococcus aureus cells, and no visible damage to Escherichia 
coli cells was observed after treatment with TDA. It is in this thesis hypothesized that TDA does not 
have to enter the interior of a bacterial cell to reach its target, and the cell envelope is suggested to 
contain the target site(s). This is in agreement with the biosensor results that also identify the cell 
envelope and possibly the peptidoglycan structure as target. 
This thesis concludes that antagonistic Phaeobacter and Ruegeria strains colonize turbot larvae 
rearing units using different water sources. Production of TDA among these strains is highly growth 
dependent. The fact that Phaeobacter strains produce TDA at more versatile conditions make them 
promising probiotic candidates in aquaculture as stagnant conditions rarely are found in a fish tank. 
Furthermore, the fact that resistance to TDA is difficult to provoke, and that the tolerant phenotype 
seen are highly unstable makes TDA producing bacteria interesting for control of bacterial diseases 
in aquaculture. Also, TDA could have potential as antibiotic for treating bacterial infections in e.g. 
humans, however, further studies are needed to evaluate this potential. 
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Resumé (in Danish) 
I dag bruges antibiotika til at kontrollere bakterielle sygdomme i akvakultur. Der er et stigende 
behov for alternative kontrolmetoder pga. risikoen for udvikling af antibiotikaresistens og 
overførsel af resistens til andre bakterier fx humanpatogene bakterier. Probiotika, hvilket er 
”levende organismer, der når de bliver administreret i passende mængder, har en fordelagtig effekt 
på værtens helbred” (FAO/WHO, 2001) kan sandsynligvis bruges til fx kulturer af fiskelarver. 
Phaeobacter og Ruegeria arter, der tilhører den marine Roseobacter gruppe, er blevet forslået som 
probiotiske organismer i akvakultur. De hæmmer og dræber fiskepatogene bakterier in vitro, og de 
kan reducere dødeligheden blandt fiskelarver inficeret med fiskepatogene bakterier. Det er forslået, 
at denne effekt skyldes produktion af den sekundære metabolit ”tropodithietic acid” (TDA). 
Formålet med dette ph.d. studie har været at undersøge forekomsten af antagonistiske bakterier 
tilhørende Roseobacter gruppen i akvakultur samt at bestemme under hvilke vækstforhold disse 
stammer danner TDA. 
Arbejde i dette ph.d. studie har vist, at et dansk pighvar opdræt var koloniseret med roseobactere 
bakterier, der hæmmede den fiskepatogene bakterie Vibrio anguillarum stamme 90-11-287. 
Stammer isoleret fra produktionen (fx fisketanke) blev vha. fænotypiske tests og 16S rRNA 
fylogeni identificeret som Phaeobacter inhibens og Phaeobacter gallaeciensis-lignende, mens 
stammer isoleret fra algekulturer var identiske med Ruegeria mobilis. Phaeobacter og Ruegeria 
stammer er tidligere påvist at kolonisere spanske pighvar opdræt. De spanske stammer viste stor 
lighed fænotypisk og ved 16S rRNA fylogeni til de danske stammer. Til trods for der bruges 
forskelligt vand i de to opdræt (galisisk Atlanterhav versus den danske fjord Limfjorden) er de 
begge koloniseret med en antagonistisk Phaeobacter / Ruegeria population. 
Alle Phaeobacter og Ruegeria stammer isoleret fra det danske pighvar opdræt producerede TDA 
under stillestående vækstforhold, og denne fænotype forekom samtidig med evnen til at hæmme V. 
anguillarum stamme 90-11-287, evnen til at vokse i roset-lignende strukturer og produktion af 
brunt pigment. Alle danske Phaeobacter stammer udtrykte også disse fænotyper under rystede 
vækstforhold, mens dette ikke var tilfældet for Ruegeria stammerne. Den eneste undtagelse fra dette 
mønster er stamme 27-4, som er identificeret til at være en Phaeobacter, men opfører sig som en 
Ruegeria. 
Det blev udført mange forsøg på at lave TDA resistente mutanter, men der blev ikke isoleret nogle 
mutanter. Det er forslået at TDA har mange ’target sites’ i bakterieceller, hvorfor resistens kræver 
adskillige mutationer i cellen, hvilket er utænkeligt at ville finde sted. Stammer med svagt forøget 
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tolerance overfor TDA blev fundet efter lang tids påvirkning med koncentrationer af TDA, der ikke 
hæmmer væksten af bakterien. Denne tolerance forsvandt efter en passage i medie uden TDA. I 
denne afhandling foreslås det, at denne midlertidige tolerance forårsages af en fænotypisk 
forandring, der hurtigt kan ændres tilbage. Dette kan skyldes fx ændring i genekspression. 
Dette ph.d studie har vist at TDA er baktericidal mod både Gram-positive og Gram-negative 
bakterier, dog er de Gram-positive mest følsomme overfor TDA. Hverken efflux pumper eller 
poriner er involverede i den medfødte resistens hos Gram-negative bakterier. TDA er virksomt mod 
både Salmonella Typhimurium og Staphylococcus aureus celler der vokser og ikke vokser, og der 
blev ikke observeret nogen synlige skader på Escherichia coli celler behandlet TDA. Det foreslås i 
denne afhandling at TDA ikke behøver at trænge ind i cellen for at nå sit target, og at cellevæggen 
eller cellemembranen indeholder target site(s). Disse to strukturer blev også identificeret vha. 
biosensorer og mere specifikt peptidoglykan-laget. 
Det konkluderes i denne afhandling at antagonistiske Phaeobacter og Ruegeria stammer 
koloniserer pighvar opdræt, der anvender forskellig vand forsyning. Produktion af TDA blandt disse 
stammer er afhængigt af vækstforholdene, og det faktum at Phaeobacter stammer producerer TDA 
under mere alsidige forhold gør dem til lovende probiotiske kandidater i akvakultur, idet 
stillestående forhold er sjældne i fiskeopdræt. Den kendsgerning, at det er svært at fremprovokere 
resistens overfor TDA samt at den tolerante fænotype er meget ustabil, gør TDA producerende 
bakterier interessante til kontrol af bakterielle fiskesygdomme i akvakultur. Desuden kan TDA have 
potentiale som antibiotika til behandling af bakterielle infektioner i fx mennesker, men yderligere 
studier er nødvendige for at afdække dette potentiale. 
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1 Introduction 
Fish is a very important food source and provides more than 2.9 billion people with at least 15 
percent of their average per capita animal protein intake. Actually, the majority (77%) of world total 
fish production was in 2006 used for direct human consumption (FAO/WHO, 2009). During the last 
decades, wild capture fisheries have stagnated whereas aquaculture, which is rearing of live aquatic 
animals, has grown rapidly (Figure 1.1). This makes aquaculture both an essential food source but 
also an important industry worldwide. 
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Figure 1.1 World fish production divided into 
wild captures and fish raised in aquaculture 
(closed symbols) and estimates for the following 
decades (open symbols) (FAO/WHO, 2009) 
Fish reared in aquaculture are exposed to a variety of both physiological and social stresses, which 
can make them more vulnerable with regard to spread of infectious diseases. As this production 
form is very intense, it facilitates spreading of pathogenic organisms between the individuals. 
Diseases can be caused by parasites, viruses, fungi and bacteria but this thesis will only focus on 
bacterial infections. Despite successful vaccination programs, it is not un-common in aquaculture to 
control pathogenic bacteria with antibiotics. However, with this comes the risk of antibiotic residues 
in fish food products but also the fear of emergence of antibiotic resistant bacteria (Seyfried et al., 
2010). This has some serious side effects as antibiotics are no longer effective against the pathogens 
(Karunasagar et al., 1994; Tendencia & de la Pena, 2001), which can lead to treatment failure. 
Furthermore, resistance genes can be transferred between bacteria including human pathogenic 
bacteria as recipients (Son et al., 1997; Schwarz et al., 2001). Therefore, antibiotic resistance 
originating from aquaculture can potentially be transferred to human pathogens and in worst case 
scenario cause disease treatment failure in humans. The European Union and USA have banned or 
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restricted the use of several antibiotics in animal production because of that (Kesarcodi-Watson et 
al., 2008). As a result, there is an urgent need for alternative methods to control bacterial infections. 
Vaccination of fish has indeed proven to be an efficient alternative for controlling bacterial 
infections. A good example is Norway where the use of antibiotic decreased from approx. 50 metric 
tonnes per year in 1987 to 746.5 kg in 1997, and at the same time aquaculture production increased 
from 5 x 104 to 3.5 x 105 metric tones (Verschuere et al., 2000b). This is ascribed to introduction of 
efficient vaccines. However, during hatching and in the larval stage the size of the fish and the slow 
development of the immune system make it difficult to use vaccines. Also, invertebrates such as 
crustaceans and mollusks, which lack acquired immunity, cannot successfully be vaccinated. 
An alternative disease control strategy, which seems very promising in aquaculture, is the use 
probiotics. Probiotics are “live organisms which when administered in adequate amounts confer a 
health benefit on the host” (FAO/WHO, 2001). This approach is promising in several cases 
including those where vaccines are not an option. Many bacteria have been tested for their in vitro 
antagonistic effect against fish pathogenic bacteria and some of the potential probionts have also 
been tested in in vivo challenge trails (Ringø & Vadstein, 1998; Huys et al., 2001; Vaseeharan & 
Ramasamy, 2003; Gullian et al., 2004; Planas et al., 2006). One group of bacteria that is receiving 
increasing attention in the marine aquaculture area is the so-called Roseobacter clade. 
Bacteria belonging to the Roseobacter clade are commonly found in marine environments such as 
ocean surface water but they are also associated with algae and colonize marine surfaces (Dang & 
Lovell, 2002a; Buchan et al., 2005). Phaeobacter spp. and Ruegeria mobilis, which belong to the 
Roseobacter clade, are commonly found in marine larval rearing systems (Ruiz-Ponte et al., 1998; 
Hjelm et al., 2004b; Porsby et al., 2008; Prado et al., 2009). Phaeobacter gallaciencis, Ph. inhibens 
and Ruegeria mobilis are able to inhibit growth of or kill a variety fish pathogenic bacteria (Ruiz-
Ponte et al., 1999; D'Alvise et al., 2010) but they are not lethal to egg yolk sac turbot larvae (Hjelm 
et al., 2004a). The antagonistic effect against other pathogenic bacteria is likely to be due to 
production of the secondary metabolite tropodithietic acid (TDA). 
It is hypothesize that production of TDA is an important competitive phenotype for bacteria such as 
Ph. gallaeciensis, Ph. inhibens and R. mobilis both in their natural oceanic niches but also in 
aquaculture settings. However, if they are to be used as probiotics in aquaculture, the microbiota in 
the fish tank probably will be exposed to TDA. Therefore, this thesis focuses on the TDA 
production in Ph. gallaeciensis, Ph. inhibens and R. mobilis and the effect of TDA on other 
bacteria. In the latter area, we focus specifically on potential resistance or adaptation in target 
bacteria. 
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The purpose of the present PhD study has been to investigate occurrence of antagonistic 
Roseobacter clade strains in aquaculture and to determine the growth conditions under which these 
strains produce TDA (paper 1). Also, the thesis has evaluated the risk/likelihood of development of 
resistance and tolerance to TDA (paper 2). Work addressing TDA mechanism-of-action (using gene 
expression analyses in target bacteria) is in progress but has unfortunately not been finished before 
deadline.  
This thesis consists of an overview section and two papers/manuscripts. The overview section 
describes probiotic organisms, their possible mechanism-of-actions and potential use in aquaculture 
(chapter 2). It also introduces the Roseobacter clade (chapter 3) and it describes production of TDA 
especially by Phaeobacter and Ruegeria stains (chapter 4). Finally, the effect of antimicrobials on 
other bacteria with regard to targets in the bacterial cell and resistance mechanisms are described 
(chapter 5). The experimental work and the results obtained during the Ph.D. study are described in 
two papers/manuscripts, however, results will also be presented in the overview section when 
appropriate.
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2 Probiotic in aquaculture 
The first discovery of probiotic organisms was reported in 1908 where Elie Metchnikoff observed 
that a large number of people in Bulgaria became more than 100-years. The author linked this 
observation to large consumptions of yoghurt and afterwards isolated bacteria from the yoghurt. 
Metchnikoff concluded that the bacteria were the cause of a health promoting effect (referred in 
(Gillor et al., 2008)). During recent years, both scientists, companies and the general public have 
turned attention to the concept of probiotics. 
The term “probiotic” literally means “for life” and originates from combining the Latin word pro 
(for) and the Greek word bios (life) (Zivkovic, 1999). It was introduced in the 1970s but the first 
widely accepted definition of probiotics for warm-blooded animals was “a live microbial feed 
supplement which beneficially affects the host animal by improving its intestinal microbial 
balance” (Fuller, 1989). This definition associates the probiont with feed, but in aquaculture the 
surrounding environment (e.g. the culture water) is also an important medium for exposing the fish 
to the probiont (Gomez-Gil et al., 2000). Therefore, Gatesoupe (1999) modified it to “microbial 
cells that are administered in such a way as to enter the gastrointestinal (GI) tract and to be kept 
alive, with the aim of improving health”. So far it has been assumed in the definition that the 
probiont should exerts its effect on the GI tract, however, in aquaculture the skin and the gills of a 
fish is just as important niches for invasion and proliferation of pathogenic bacteria and the 
probiotic organism can just as well be applied through those routes (Gram et al., 2005). 
Consequently, Gram et al. (1999) broadened up the definition to “a live microbial supplement 
which beneficially affects the host animal by improving its microbial balance”. However, 
“microbial balance” is not very well described. Thus, the definition on probiotics used in this thesis 
is “live organisms which when administered in adequate amounts confer a health benefit on the 
host” (FAO/WHO, 2001). One may note that this FAO/WHO definition broadens the probiotic 
concept for all hosts, also warm-blooded animals. Adding beneficial microorganism to the water in 
aquaculture does on one hand resemble plant biocontrol as the microorganisms exert their effect on 
the outside (the skin and in the gills). On the other hand, it is very well possible that some are 
ingested and may act via the GI tract. 
The definition of probiotic organisms from FAO/WHO states that it should have “a health benefit 
on the host”. Gram & Ringø (2005) discuss that even though alterations in microbial composition 
may affect survival of fish, this is not necessarily a prerequisite for a successful probiotic culture. 
The authors proposed that the effect of a probiotic organism should be measured as “its ability to 
decrease frequency of disease and/or increase survival from lethal diseases”. 
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2.1 Mechanism­of­action of probiotic cultures 
The mechanism-of-action causing the effect of a probiotic bacterium is rarely known. Most often, a 
correlation is made between the in vitro observations that a pathogenic bacterium is inhibited and 
the in vivo disease reducing effect of the same potential probiotic bacterium (Verschuere et al., 
2000b). A probiotic organism can most likely exert its effect through more than one mechanism-of-
action resulting in a collective effect on the host. 
2.1.1 Antagonistic compounds 
In this thesis, antagonistic compounds are defined as a chemical compounds produced by a 
probiotic organism and it is either bactericidal or bacteriostatic against other microorganisms. If 
bacteria producing such compounds are present in the intestine, on surfaces of the host or in the 
culture water, where the host is farmed, then it is believed to either prevent proliferation of 
pathogenic bacteria or to kill them. Examples of general antagonistic compounds are antibiotics, 
bacteriocins, siderophores, lysozymes, proteases, hydrogen peroxide, ammonia and diacetyl but also 
production of organic acids, which alters the pH value, is considered an important factor. 
There are numerous studies showing that different bacteria can antagonize aquaculture pathogens in 
vitro (Westerdahl et al., 1991; Bergh, 1995; Sugita et al., 1997; Jorquera et al., 2000; Longeon et 
al., 2004; Bruhn et al., 2005; Jayaprakash et al., 2005; Rattanachuay et al., 2010; Bjornsdottir et al., 
2010), however, as shown by Gram et al. (2001) this is no guarantee that the probiotic organism 
will exert a similar effect in vivo (Figure 2.1). 
 
Figure 2.1 Accumulated mortality of Atlantic salmon 
(Salmo salara L.) infected with Aeromonas salmonicida 
with and without treatment ( ) with Pseudomonas 
fluorescens strain AH2 at two levels: 0 – 105 ( ) and 103 
– 105 ( ) cfu/ml, respectively. Fish of 15 – 20 gram sizes 
were kept in fresh water at 12°C with a flow of 0.8 l/kg 
fish per minute. Infection was done by 10% cohabitants 
and all treatments were carried out in triplicates. Error 
bars are 95% confidence limits (Gram et al., 2001) 
A few in vivo studies have suggested that the probiotic effect is caused by production of 
antagonistic compounds but the compound is not always identified (Table 2.1). Most of the 
experiments are conducted on shellfish larvae. It has never been shown in in vivo experiments, e.g. 
by measuring the concentration of the antagonistic compound, that the observed probiotic effect is 
2 Probiotic in aquaculture 
  7 
caused by the compound of interest. It is suggested in this thesis that using a mutant, which does not 
have the ability to produce the antagonistic compound, as a control in an in vivo infection study 
could indirectly show if the probiotic effect is due to that phenotype.  
Table 2.1 Possible probiotic bacteria producing antagonistic compounds tested in in vivo studies 
Producer strain Pathogen inhibited Possible 
compound 
Probiotic against Reference 
Unidentified 
strain PM-4 
Vibrio ssp.  Unknown Shrimp larvae  
(Penaeus monodon) 
(Maeda & Liao, 1992); 
(Maeda, 1994) 
Vibrio sp. Vibrio anguillarum 
related 
Unknown Scallop larvae 
(Argopecten purpuratus) 
(Riquelme et al., 1997) 
Aeromonas media 
strain A199 
Vibrio tubiashii 2,3-benzopyrrole Pacific oyster larvae 
(Crassostrea gigas) 
(Gibson et al., 1998); 
(Lategan et al., 2006) 
Roseobacter 
strain BS107 
Vibrio anguillarum Proteinaceous, heat 
stable 
Scallop larvae  
(Pecten maximus) 
(Ruiz-Ponte et al., 1999) 
Roseobacter 
strain 27-4 
Vibrio anguillarum Tropodithietic acid Turbot larvae 
(Scophthalmus maximus) 
(Planas et al., 2006); 
(Bruhn et al., 2005) 
If the mechanism-of-action of a probiotic bacterium is due to an antagonistic compound then 
development of resistance against that compound has to be taken into account. It will lead to either 
ineffective or even treatment failure if bacteria in the aquaculture environment including the 
pathogenic organisms develop resistance. Tropodithietic acid (TDA) producing bacteria have been 
suggested as probiotic organisms and it would therefore be relevant to study if resistance to this 
compound can develop. This aspect has been evaluated in this thesis and it was difficult to create 
resistant mutants or strains with a stable, elevated tolerance to TDA. This enhances the potential of 
TDA producing bacteria as probiotics in aquaculture. 
2.1.2 Competition for nutrients 
Competition for nutrients is considered a mechanism-of-action when using probiotic organisms in 
aquaculture as it can interfere with the composition of the microbiota in culture water or on surfaces 
on the host. The microbiota is generally dominated by heterotrophs, which compete for organic 
substrates as carbon and energy sources (Verschuere et al., 2000b). However, only a few in vivo 
studies have been conducted within this area. Rico-Mora et al. (1998) isolated a bacterium due to its 
ability to grow in organic-poor media and showed that this bacterium protected a diatom culture 
against establishment of Vibrio alginolyticus. The authors suggested that the effect was caused by 
the ability of the bacterium to utilize exudates from the diatom. In another study, Verschuere et al. 
(2000a) saw that several strains had a positive effect on the survival and growth of Artemia 
juveniles and protected them from Vibrio proteolyticus. The effect was only observed using living 
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cell culture as opposed to supernatant. Hence, it was concluded that the probiotic effect was due to 
competition for chemicals and available energy. 
Iron is essential for most organisms and although abundant, it is largely unavailable since it is 
bound in insoluble complexes (Hider & Kong, 2010). Hence, most microorganisms have developed 
strategies for acquisition of iron, and one of the most common strategies for iron acquisition is 
siderophore production (Hider et al., 2010). Siderophores are low-molecular-weight iron chelating 
agents that can dissolve complex bound iron and make it available for microbial growth by up-take 
of the Fe-siderophore complex via specific receptors. If a probiotic bacterium uses siderophores as 
an inhibitory mechanism-of-action it will scavenge iron from the environment and thereby limit 
growth of pathogenic bacteria. Gatesoupe (1997) saw in in vitro experiments that Vibrio strain E 
produced siderophores, and that this strain in vivo protected turbot larvae (Scophthalmus maximus 
L.) from a pathogenic Vibrio strain P. The author proposed that that the probiotic effect was at least 
partly due to competition for iron. Bacillus cereus strain NRRL 100132 exhibited a protective effect 
on common carps (Cyprinus carpio) against Aeromonas hydrophila in an in vivo study (Lalloo et 
al., 2007). It was later concluded through in vitro experiments that the positive effect was due to 
competition for organic carbon and iron facilitated by siderophore production, but also due to the 
fact that the probiotic organism had a higher growth rate as compared to the pathogenic bacteria 
(Lalloo et al., 2010). Gram et al. (1999) and Spanggaard et al. (2001) demonstrated that several 
fluorescent pseudomonads were able to reduce vibriosis-induced mortality in rainbow trout 
(Oncorynchus mykiss). They suggested that siderophore production could, in part, be the cause of 
the disease protective effect since the fish pathogen V. anguillarum was not inhibited in vitro when 
the growth media were supplemented with iron. Gene expression studies supported that the 
probiotic effect could be due to siderophore production (Holmstrøm & Gram, 2003). 
2.1.3 Competition for attachment sites 
A pathogenic bacterium needs to attach and proliferate on surfaces of the host in order to cause 
infection. However, if these surfaces are already occupied then successful adhesion and 
colonization will probably be prevented. Olsson et al. (1992) showed that possible probiotic 
bacteria originating from the intestine of turbot adhered and grew better to/on fish intestinal mucus 
than did the pathogenic Vibrio anguillarum. This indicates that they perhaps would be able to 
compete with the pathogen for attachment sites. However, the possible probiotic organisms 
produced compounds that were antagonistic against the V. anguillarum, indicating that they perhaps 
could combine different mechanisms-of-actions. 
Many studies have demonstrated the ability of possible probiotic organisms to adhere to intestinal 
mucus in vitro, but they did not evaluate the ability to exclude pathogenic bacteria from this surface 
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(Krovacek et al., 1987; Olsson et al., 1992; Garcia et al., 1997; Jöborn et al., 1997). However, Vine 
et al. (2004) found that a possible probiotic bacteria isolated from clownfish (Amphiprion percula) 
were able to both prevent attachment of V. alginolyticus but also remove the pathogen from the 
surface. 
Roseobacter clade strains are among the first bacteria to colonize surfaces in marine environments 
(Dang & Lovell, 2000), and some have been suggested as probiotic organisms (Ruiz-Ponte et al., 
1999; Hjelm et al., 2004a). It has been shown that Phaeobacter and Ruegeria species under specific 
growth conditions have a high attachment capacity and produce an antagonistic compound (TDA) 
(Porsby et al., 2008). However, these phenotypes seen in vitro did not facilitate the colonization of 
the turbot larval gut in an in vivo study where Phaeobacter strain 27-4 were administered via live 
food (rotifers) (Planas et al., 2006). The strain was primarily found in the culture water. 
2.2 Probiotic bacteria used to control diseases in aquaculture 
Vaccination has proven to be a successful approach to control diseases among many species of fish. 
For fish larvae, crustaceans and mollusks this strategy is not possible, and the possible effect of 
probiotics has therefore been the focus of several in vivo experiments. This section will only present 
a few examples of such studies. For further studies see e.g. review by Balcázar et al. (2006) and 
Kesarcodi-Watson et al. (2008). 
2.2.1 In vivo probiotic studies with finfish larvae 
The probiotic effect of a range of bacteria such as Bacillus toyoi, Vibrio pelagius, Vibrio 
mediterranei, V. alginolyticus, V. salmonicida, Vibrio iliopiscarius, Microbacterium sp., Ruegeria 
sp., Pseudoalteromonas sp., Carnobacterium divergens, Streptococcus lactis and Lactobacillus 
bulgaricus, L. plantarum on finfish larvae such as e.g. turbot, halibut (Hippoglossus hippoglossus 
L.) and cod (Gadus morhua L.) have been investigated (Gatesoupe, 1989; Gatesoupe, 1990; Garcia 
De La Banda et al., 1992; Ringø et al., 1998; Ottesen & Olafsen, 2000; Huys et al., 2001; Fjellheim 
et al., 2010). Some strains increased survival of larvae whereas others had an adverse effect leading 
to faster killing as compared to the control larvae only exposed to rearing water (Figure 2.2). This 
emphasizes the importance of testing potential probiotic bacteria in in vivo studies. 
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Figure 2.2 Survival of cod (Gadus morhua L.) larvae 
when they were exposed to the bacterial density 104 
cfu/ml of seven probiotic candidates, a negative and a 
positive control. Negative control was Vibrio 
anguillarum O2a, positive control was non-sterilized 
rearing water (5.9 x 102 cfu/ml). Positive control ( ), 
negative control ( ), Vibrio anguillarum strain RA 3-
6 ( ), Ruegeria sp. strain RA 4-1 ( ), 
Pseudoalteromonas sp. strain RA 7-14 ( ), 
Microbacterium sp. strain ID 3-10 ( ), Vibrio gallicus 
strain RD 5-30 ( ), Microbacterium sp. strain ND 2-7 
( ), Vibrio anguillarum strain ID 4-29 ( ). Modified 
from (Fjellheim et al., 2010) 
Roseobacter strain 27-4 (reclassified as a Phaeobacter gallaeciensis (Martens et al., 2006)) was 
isolated from the tank walls of a turbot rearing unit due to its antimicrobial effect against V. 
anguillarum and Vibrio splendidus species (Hjelm et al., 2004a). The authors showed that the strain 
significantly increased the survival of egg yolk sac turbot larvae as compared to the non-challenged 
control. A similar study also showed a positive effect on survival turbot larvae due to another 
Roseobacter strain, however, the effect was not significant (Makridis et al., 2005). Planas et al. 
(2006) evaluated the probiotic effect of Phaeobacter strain 27-4 on turbot larvae against V. 
anguillarum by incorporating the probiont and the pathogenic bacterium into live food (rotifers). 
When the larvae received both Phaeobacter strain 27-4 and V. anguillarum the accumulated 
mortality was either similar to the control (larvae fed with non-enriched rotifers) or lower than the 
value for larvae fed rotifers loaded with V. anguillarum (Figure 2.3). The authors also demonstrated 
that the probiont did not colonize the larval gut but it was mainly found in the culture water. This 
indicates that Phaeobacter strain 27-4 acts in the water or in surface biofilms similar to where it 
was isolated from. 
Also mixtures of bacterial strains have a probiotic effect against finfish larvae. Makridis et al. 
(Makridis et al., 2008) found that a mixture of Shewanella strain 2J27 and an unidentified Gram-
positive bacterium increased survival of sole larvae (Solea senegalensis) 20 days after hatching. 
Cod and halibut larvae treated with a mix of Carnobacterium divergens V41 / Arthrobacter sp. / 
Enterococcus sp., and Pseudomonas sp. / Cytophaga/Flavobacterium sp., respectively, resulted in 
higher survival rates as compared to the non-treated control (Skjermo & Vadstein, 1999; Lauzon et 
al., 2010). 
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Figure 2.3 Accumulated mortalities in turbot larvae. VR: larvae were fed with rotifers loaded with Phaeobacter 
strain 27-4 (day 3, 5 and 7), with rotifers loaded with Vibrio anguillarum strain 90-11-287 (day 4, 6 and 8) and 
with non-enriched rotifers (day 9 and 10). V: larvae fed on rotifers loaded with Vibrio anguillarum strain 90-11-
287 (day 4, 6 and 8). Control: larvae fed non-enriched rotifers. Three independent experiments are shown 
(Planas et al., 2006) 
2.2.2 In vivo probiotic studies with crustaceans 
Most studies on crustaceans have been done on shrimps infected with a Vibrio species and the 
probiotic effect of e.g. Bacillus, Vibrio and Pseudomonas species (Rengpipat et al., 2000; 
Vaseeharan et al., 2003; Alavandi et al., 2004; Gullian et al., 2004). Infection of shrimps with 
Vibrio harveyi led to 100% mortality after 17 days, but when the shrimps were exposed to the 
probionts Bacillus subtilis strain BT23 for five days prior to infection the accumulated mortality 
only reached 32% (Figure 2.4) (Vaseeharan et al., 2003). A short-time exposure of one hour before 
infection decreased the mortality to 60%. However, a synergistic effect was obtained by combining 
the two procedures resulting in the lowest accumulated mortality. 
Commercial probiotic products for shrimps containing a single bacterial strain of or a mixture of 
Bacillus species are already available on the marked (Moriarty, 1998; McIntosh et al., 2000). 
Castex et al. (2008) studied the in vivo probiotic effect of a commercial product containing the 
lactic acid bacterium Pediococcus acidilactici on shrimps (Litopenaeus stylirostris) infected with 
Vibrio nigripulchritudo. They observed a significant increase not only in the number of surviving 
shrimps but also in the final biomass due to probiotic treatment. P. acidilactici survived and 
withstood the conditions in shrimp digestive tract, but the beneficial bacteria did not colonize it. 
This might indicates that continuously addition of the probionts is necessary. 
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Figure 2.4 Accumulated mortalities in shrimp 
juveniles infected with Vibrio harveyi with and 
without probiotic treatment of Bacillus subtilis 
strain BT23.  control, ▲ long-term treatment, ■ 
short-term treatment, ♦ combined treatment 
(Vaseeharan et al., 2003) 
The in vivo probiotic effect of Thalassobacter utilis strain PM-4 on swimming crab (Portunus 
trituberculatus) larvae was repeated over a five years time period (Nogami et al., 1997). The 
probiont, which was isolated from culture water (Nogami & Maeda, 1992), was added to the culture 
water at 105 - 106 cfu/ml once every 6 - 8 days. Not only did the probiont improve the survival rate 
of treated larvae compared to non-treated animals, also the number of individuals per m3 increase 
and only one production failed as compared to 12 for the non-treated larvae (Table 2.2). 
Table 2.2 Survival and production of swimming crab (Portunus trituberculatus) treated with Thalassobacter utilis 
strain PM-4. Modified from (Nogami et al., 1997) 
Year Addition of 
probiont 
No. of 
trials 
Larval no. 
at start 
Avg. survival rate 
(%) to 1st crab stage 
Final production 
(individuals/m3) 
No. of production 
failures 
1989 - 10 46,960,000 22.0 5,158 0 
 + 4 20,300,000 30.4 7,703 0 
1990 - 9 42,930,000 6.8 1,617 4 
 + 7 30,570,000 26.7 5,838 0 
1991 - 7 34,150,000 10.4 2,543 4 
 + 7 34,790,000 27.9 6,938 0 
1992 - 8 35,710,000 17.8 3,963 3 
 + 9 37,410,000 28.8 5,994 1 
1993 - 8 33,200,000 21.6 4,474 1 
 + 6 26,610,000 27.7 6,150 0 
Total - 42 192,950,000 15.7 3,605 12 
 + 33 149,680,000 28.2 6,397 1 
2.2.3 In vivo probiotic studies with mollusks 
Many initiatives have been tried in order to solve the problem with enormous losses of oyster larvae 
due to bacterial infections. Gibson et al. (1998) treated Vibrio tubiashii infected Pacific oysters 
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(Crassostrea gigas) larvae with the probiont Aeromonas media by adding it to the culture water. All 
larvae died within five days when infected with the pathogenic bacterium, but when adding the 
pathogen and the probiont together, the number of V. tubiashii decreased and resulted in complete 
survival of oyster larvae during the same time period. The probiotic effect is probably due to 
antagonistic activity of the compound 2,3-benzopyrrole (Lategan et al., 2006). 
Riquelme et al. (1997) tested 506 bacterial isolates for their in vitro ability to inhibit a V. 
anguillarum-related strain. A Pseudomonas strain, which had in vitro effect, and an unidentified 
isolate with no in vitro effect were tested in vivo. Both improved survival of Chilean scallop 
(Argopecten purpuratus) larvae from 5% to 60% when infected with a V. anguillarum-related 
strain. On the other hand, the authors showed that 2.2% of the 506 isolates were able to inhibit 
growth of the pathogenic bacterium in vitro, but in vivo several of them increased the mortality of 
the larvae. Again, this emphasizes the importance of conducting in vivo studies. Also Ruiz-Ponte et 
al. (1999) saw a difference between results obtained in vitro and in vivo.  Roseobacter strain BS107 
(reclassified as Ph. gallaeciensis (Martens et al., 2006)) were able to inhibit a variety of different 
marine strains in in vitro tests. When scallop (Pecten maximus) were infected with Vibrio strain 
A496 and treated with Ph. gallaeciensis strain BS107, neither whole cells nor cell extracts protected 
the larvae against the infection, but the cell extract decreased the natural mortality among non-
infected larvae. 
2.3 Addition of probiotic bacteria 
One of the challenges when it comes to use of probiotic organisms in aquaculture is addition of the 
probiont to the host. The following delivery routes can be used (Verschuere et al., 2000b): 
 Bath of the host in a suspension of the probiotic organism 
 Addition of the probiotic organism to the culture water in the tanks 
 Administered as addition to the artificial diet 
 Addition via live feed 
Few studies have been conducted where the host has been bathed in a suspension the probiont  
(Riquelme et al., 1997; Suomalainen et al., 2005), whereas most studies have administered the 
probiotic organism by addition to the culture water (Makridis et al., 2005; Ravi et al., 2007; 
Fjellheim et al., 2010) or to the diet or feed (Planas et al., 2006; Aly et al., 2008). These latter two 
methods are probably less stressful to the fish/larvae as compared to bathing due to less handling of 
the animals. All these routes may require multiple, continuously additions of the probiont in order 
to maintain an effective level of the probiont in the rearing system. However, the idea in our 
research group is to make the probiotic bacteria colonize surfaces within the rearing facilities which 
are in contact with the culture water e.g. tank walls or biofilters and thereby creating a more stable 
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beneficial microbial colonization of the fish environment. This will, hopefully, restrict growth of 
fish pathogenic bacteria thus controlling bacterial diseases. 
2.4 Conclusions from chapter 2 
The main mechanisms-of-actions of probiotic organisms are probably (i) production of antagonistic 
compounds, (ii) competition for nutrients and (iii) competition for attachment sites, however, it is 
likely that the probiotic effect is due to a combination of more than one mechanism. Using probiotic 
bacteria in aquaculture seems like a promising way to control diseases and e.g. some members of 
the Roseobacter clade have a disease reducing effect in in vivo challenge trials. The Roseobacter 
clade bacteria tested in aquaculture produce the antibacterial compound TDA, and there seems to be 
a correlation between the production of TDA and growth of roseobacters in a biofilm stage. One 
could therefore hypothesize that an application in which the roseobacters is applied as biofilms 
could create a stable, beneficial microbiota in the fish tanks. This hypothesis is currently under 
investigation by PhD student Paul D’Alvise (D'Alvise et al., 2010). 
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3 Roseobacter clade bacteria 
Culturable bacteria of the Roseobacter clade was first isolated by Shiba et al. (1979) approximately 
30 years ago, but were not classified as the newly established Roseobacter clade until 1991 (Shiba, 
1991). Since then, new genera and species have been repeatedly added to the clade and today it 
contains approximately 38 genera of which many only contain one species (Brinkhoff et al., 2008). 
The Roseobacter clade belongs to the α-proteobacteria and consists of both culturable and non-
culturable members. Members of the clade share more than 89% identity of the 16S rRNA gene 
(Buchan et al., 2005) and based on 16S rRNA gene similarity, they fall into different clusters 
(Brinkhoff et al., 2008). However, at some nodes, especially those distinguishing deep branching 
points, the statistical power is poor, and does not provide a clear phylogenetic relationship. 
Therefore, Newton et al. (2010) compared 70 universal single-copy genes from 32 genome 
sequences of Roseobacter clade members, and this analysis resulted in five deeply branching clades 
(Figure 3.1). More or less the same clade-pattern was published by Tang et al. (2010) by comparing 
1,197 single-copy genes from 17 of the same 32 genomes. The only difference was that 
Maritimibacter alkaliphilus HTCC2654 in the latter study grouped together with stains in clade 5 
whereas it did not affiliate with any clusters in Figure 3.1. 
Members of the Roseobacter clade are Gram-negative rods and some produce pigments resulting in 
colored colonies on agar (Shiba, 1991; Ruiz-Ponte et al., 1998; Martens et al., 2006; Muramatsu et 
al., 2007; Zhang et al., 2008; Vandecandelaere et al., 2009): 
 Pink (Roseobacter denitrificans and Roseobacter litoralis) 
 Brown (Phaeobacter gallaeciensis, Phaeobacter inhibens and Ruegeria mobilis) 
 Yellow (Phaeobacter arcticus) 
 Blue (Phaeobacter caeruleus) 
It has been speculated, if the pigment is produced for UV protection of the bacterial cell (a 
sunscreen) (Battistuzzi et al., 2004). Indeed, a brown pigment such as melanin has this protective 
effect in other bacteria (Patel et al., 1996; Hullo et al., 2001; Ruan et al., 2003). Alonso-Sáez et al. 
(2006) demonstrated that bacterial activity (ATP and leucine uptake) of roseobacters increased 
when exposed to photosynthetic radiation as compared to dark treatment. Some roseobacters do 
under certain conditions grow in multi-cellular star-shaped rosettes or aggregates (Figure 3.2) 
(Rüger & Höfle, 1992; Bruhn et al., 2005) and eight out of 14 Roseobacter clade strains tested by 
Bruhn et al. (2007)  showed this phenotype. 
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Figure 3.1 A consensus maximum likelihood tree of the 32 sequenced Roseobacter genomes. The alignment for 
tree inference was created from a concatenation of 70 universal single-copy genes contained in each of the 
Roseobacter genomes and in Escherichia coli strain K12, which was used as an outgroup. Bootstrap values of 
more than 50% for the maximum likelihood best-fit tree (200 iterations) and neighbor-joining tree (100 
iterations) are listed at each node. The neighbor-joining bootstrap values are listed in parentheses. (*) 
demarcates nodes where the neighbor-joining tree did not agree with the maximum likelihood tree. Designated 
Clades 1-5 are listed to the right of the tree (Newton et al., 2010) 
With a few exceptions (the genus Ketogulnicigenium and clones from a South African goldmine), 
all Roseobacter clade members are strictly marine or hypersaline, and comparison of genome 
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sequences revealed that they contain genes involved in utilizing of sodium gradients and 
osmoregulation (Moran et al., 2007). The same authors also identified 121 genes which “make a 
roseobacter a roseobacter”. Interestingly, 31% of the genes were involved in transport of 
compounds across the membrane including transport systems for e.g. glyoxylate (a product of algal 
photorespiration and organic matter photoxidation), acetate, allophanate (a breakdown product of 
urea in chlorophytes and bacteria), arginine, branced-chain amino-acids, ammonia, and secondary 
products (Moran et al., 2007). Examples of transporters are porins, which covers 70% of the outer 
membrane of R. denitrificans and the authors actually describes it as a “molecular sieve” rather than 
a membrane (Jaroslawski et al., 2009). 
 
Figure 3.2 Scanning electron microscopy micrographs of 
Phaeobacter strain 27-4 grown in marine broth under 
stagnant conditions. Modified from (Bruhn et al., 2005) 
Members of the Roseobacter clade can utilize a broad spectrum of substrates for growth including 
glucose. The genomes of Silicibacter pomeroyi strain DSS-3, Ruegeria strain TM1040 and 
Jannaschia strain CCS1 all encode a complete tricarboxylic acid cycle and harbor genes for the 
Entner-Doudoroff pathway (Moran et al., 2007). This computer-based study is in agreement with in 
vivo studies showing that Ph. gallaeciensis DSM 17395 and Dinoroseobacter shibae strain DFL12 
both utilize glucose through the Entner-Doudoroff pathway and the tricarboxylic acid cycle (Furch 
et al., 2009). Zech et al. (2009) also concluded that glucose is utilized in Ph. gallaeciensis DSM 
17395 via the Entner-Doudoroff pathway by using relative abundance changes of global proteins 
(2-D DIGE) and metabolite (GC-MS) profiles. 
Some members have alternative pathways for energy metabolism. Carbon can be derived from 
degradation of aromatic substrates originating from phenolic metabolites from marine plankton and 
liginin derivates from costal marshes (Moran & Hodson, 1994; Duval et al., 1999; Faulkner, 2000). 
Furthermore, some strains have the ability to obtain sulfur from dimethylsulphoniopropionate 
(DMSP), which originates from algae, either by the cleavage pathway where the end product is the 
gas dimethyl sulfide that may influence the global climate, or by the demethylation/demethiolation 
pathway where the sulfur is incorporated into biomass (Moran et al., 2003). Energy can be derived 
from oxidation of carbon monooxid, which is produced when sunlight oxidizes marine dissolved 
matter in seawater (Zafiriou et al., 2003; Moran et al., 2004) or by aerobic anoxygenic phototrophy 
where bacteria use light to get energy without generation of oxygen (Buchan et al., 2005). A species 
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like D. shibae posses the ability to obtain energy both from aerobic anoxygenic phototrophy and the 
tricarboxylic acid cycle. A reason could be that the species can rely on the tricarboxylic acid cycle 
when the former is not active e.g. at night or in deeper water regions. 
3.1 Roseobacter occurrence in marine environments 
The Roseobacter clade is wide-spread in many different marine environments and the bacteria are 
exposed to different conditions such low temperature or high concentrations of salts. This indicates 
that the members have a great ability to adapt to a variety of life conditions. 
3.1.1 Natural environments 
Seawater contains approximately 106 cells/ml, however, it is only a small fraction of about 0.1% of 
all the marine bacterioplankton, which are culturable (Bernard et al., 2000; Selje & Simon, 2003; 
Gram et al., 2009). Members of the Roseobacter clade are a common group among non-culturable 
bacteria in seawater (Giovannoni et al., 2000; Wietz et al., 2010). Still some members are very 
easily culturable, and it is from these that a lot of knowledge is gained about the clade. The Global 
Ocean Sampling data set contains genome shotgun sequences from the ocean (Rusch et al., 2007; 
Yooseph et al., 2007). Newton et al. (2010) compared this data set to the genome sequences from 
culturable roseobacters and found that genomes from culturable roseobacters still do not provide a 
faithful representation of the natural roseobacter population. However, many gene systems are 
indeed present. 
Roseobacter clade members have been found in seawater from the Pacific Ocean, Saragasso Sea, 
North Atlantic Ocean, Mediterranean Sea, North Sea, Antarctic Polar Front, Changjiang Estuary, 
Caribbean Sea and Black Sea, but also in many different marine environments like marsh and costal 
biofilms, various types of sediments, diatoms, corals, cephalopods, polar sea ice, sea grass, 
dinoflagellates and different types of algae (Buchan et al., 2005; Wagner-Döbler & Biebl, 2006). 
An abundance of 20-30% determined by quantifying 16S rRNA gene prevalence is not uncommon 
in coastal waters, whereas they constitute about 15% of the bacterioplankton communities in upper 
mixed layer of the ocean (Buchan et al., 2005). However, both higher and lower numbers have been 
detected. Frequencies as high as of 43% has been reported from sub-Antarctic seawater collected 
off Ushuaia, Argentina where the water was contaminated with the water soluble fractions of crude 
oil (Prabagaran et al., 2007). Another study, where samples were taken at different oceanic 
provinces, showed that the Roseobacter clade constituted 1.5% to 8.2% determined by the CARD-
FISH method (Wietz et al., 2010). Roseobacter clade members are found in the upper layer of the 
oceans and abundance decrease with water depth. Members are have often been associated with 
natural algae blooms in the oceans, and here there is also a link between abundance and water 
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depth, but furthermore, there is a positive correlation with chlorophyll a, DMSP and total organic 
sulfur (González et al., 2000; Alavi et al., 2001). These findings suggest that the members probably 
prefer surfaces-attached-living as compared to free-living in the waters. 
The term cosmopolitan are used in marine ecology to describe organisms that are everywhere, 
which is contrary to those only present in specific biogeographic niches. Some sub-groups of 
roseobacters appear to be associated with particular geographic areas such as temperate and arctic 
waters (Selje et al., 2004), whereas others are abundant in all oceans (Morris et al., 2002). Gram et 
al. (2010) found that culturable R. mobilis can be detected world-wide in almost all water masses 
(except Arctic and Antarctic waters). The R. mobilis strains are highly similar when comparing the 
16S rRNA gene sequence and they cluster closely with the type strain of R. mobilis and strains 
isolated from fish farms. Furthermore, they have all retained phenotypic traits like pigmentation, 
ability to grow in rosettes and ability to produce the antagonistic compound tropodithietic acid 
(TDA). It has been discussed if all bacterioplankton are cosmopolitan, and if it is just a question of 
detecting them, or if the true distribution is found in the marine environments (Pedros-Alio, 2006). 
Some studies have found only very few cosmopolitan organisms (Pommier et al., 2007), whereas 
others have speculated that the phenomenon is widespread and that many organisms are ubiquitous 
on a global scale (Finlay, 2002; Fenchel & Finlay, 2004). 
3.1.2 Roseobacter clade bacteria in aquaculture 
Aquaculture settings contain a diverse microbial community, which includes pathogenic, innocuous 
and beneficial bacteria, and the balance of this microbiota can be a determining factor for a 
successful culture environment. When considering the use of a probiotic bacterium to improve this 
balance, it is a good idea to use a bacterium that is already occurring in this type of environment as 
the bacteria will be adapted to the conditions and stresses it will be exposed to. Several studies have 
detected members of the Roseobacter clade in marine aquaculture systems either by denaturing 
gradient gel electrophoresis (DGGE) (Table 3.1) or by culturable isolation (Hjelm et al., 2004b; 
Prado et al., 2009). Roseobacter clade members have been isolated from aquaculture in this thesis 
work (Porsby et al., 2008). The members are sometimes among the most dominating groups of 
bacteria found in aquaculture settings (Schulze et al., 2006; Michaud et al., 2009). Moreover, the 
type strain of the species Ph. gallaeciensis (strain BS107) has been isolated from the seawater from 
larval cultures of scallops (Ruiz-Ponte et al., 1998). 
Hjelm et al. (2004b) sampled two Spanish turbot rearing facilities once a month over a 1-year 
period and found Ph. gallaeciensis especially in spring and early summer months on the culture 
tank walls. Random-amplified-polymorphic-DNA (RAPD) subtyping showed that the roseobacters 
were very homogeneous indicating either a common, regular source or that the facilities were 
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colonized by this particular RAPD subtype. In this PhD work, Ph. inhibens and Ph. gallaeciensis-
like strains were found to colonized the tanks in a Danish turbot rearing unit, however, these were 
other RAPD subtypes than the ones found in the Spanish facilities (Porsby et al., 2008). Besides 
from Phaeobacter species, which were the only antagonistic genus found in the production sites, R. 
mobilis strains were isolated from the Danish turbot farm but only in the algae cultures. 
Phaeobacter strains were also isolated from an oyster hatchery in Galicia, Spain (Prado et al., 
2009). Despite the very different water sources used in the turbot rearing farms (the Galician 
Atlantic Ocean opposed to the Danish fjord Limfjorden) and the different species raised (turbot 
versus oysters), they all harbored an antagonistic roseobacter microbiota. 
Table 3.1 Identification of roseobacters from aquaculture settings using denaturing gradient gel electrophoresis 
(DGGE) and culturable methodology 
Aquaculture system Roseobacter sp. found Isolated from Reference 
DGGE:    
Haddock larviculture Roseobacter sp. Larvae (Griffiths et al., 2001) 
Recirculation system Roseobacter sp. Biofilters (Cytryn et al., 2005) 
Hatchery that culture fish 
and shellfish species 
Ruegeria sp. 
Roseobacter sp. 
Sulfitobacter sp. 
Abelone, clam, geoduck, 
blackcod, macroalgae 
(Schulze et al., 2006) 
Cod hatchery Roseobacter sp. Nannochloropsis culture (Brunvold et al., 2007) 
Recirculation system Ruegeria sp.  
Roseobacter sp. 
Biofilters, rearing water (Michaud et al., 2009) 
Culturable:    
Scallop rearing facility Phaeobacter gallaeciensis Culture water (Ruiz-Ponte et al., 1998) 
Turbot rearing facilities Phaeobacter sp.,  
Ruegeria sp. 
Rotifers, tank walls, rearing 
water 
(Hjelm et al., 2004b) 
Turbot rearing facility Phaeobacter sp.,  
Ruegeria sp. 
Tank walls, rearing water, 
algae 
(Porsby et al., 2008) 
Flat oyster and 
clams hatcheries 
Phaeobacter sp. Oyster larvae, culture 
water, tank surfaces, spat, 
broodstock 
(Prado et al., 2009) 
The 16S rRNA gene is useful for phylogenetic comparison for many genera and species, however, 
it may not always be the best gene of choice (Dauga, 2002; Urbanczyk et al., 2007). When 
comparing the 16S rRNA gene for Danish and Spanish roseobacters isolated from turbot rearing 
units, they clustered closely together (Figure 3.3a) (Porsby et al., 2008). Species within the 
Roseobacter clade could in principle be difficult to separate based on 16S rRNA sequences as are 
other groups of organisms such as Vibrio species. Therefore, the gyraseB (gyrB) gene was in this 
thesis work used for phylogenetic comparison, as this gene has been used successfully to 
discriminate between genera and species with closely related 16S rRNA genes  
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Figure 3.3 Phylogenetic tree constructed using the 16S rRNA gene (a) and gyraseB (gyrB) gene (b). Numbers at 
the nodes are bootstrap values from 100 replicates. Type strains Rhodobacter capsulatus ATCC 11166 and 
Rhodobacter sphaeroides ATCC 17023 served as outgroups in the 16S rRNA tree, and Roseobacter denitrificans 
strain Och114 and Roseobacter litoralis strain Och149 served as outgroups in the gyrB gene tree (not shown).  
and , Danish and Spanish turbot rearing farm strains, respectively. T, type strains (Porsby et al., 2008) 
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(Fukushima et al., 2002; Yáñez et al., 2003; Richert et al., 2005; Hannula & Hänninen, 2007). 
Clustering based on the gyrB gene resulted in the same clustering as did 16S rRNA but it gave a 
greater evolutionary distance between the Danish and Spanish strains (Figure 3.3b). 
Surfaces in the oceans are covered with bacteria as this is a nutrient rich place for living, and 
therefore, there is competition for a spot on the surface. Members of the Roseobacter clade are 
among the organisms which have a preference for surfaces, and not only have they been shown to 
colonize a variety of inorganic and organic marine surfaces, but they are among the first bacteria to 
attach to a surface (Dang et al., 2000; Dang & Lovell, 2002b; Dang et al., 2008; Mayali et al., 
2008). 
It is not known specifically how roseobacters attach to a surface and how this is regulated. 
However, it is hypothesized that possession of a holdfast structure, motility, chemotaxis, production 
of quorum sensing molecules and antimicrobial metabolites are some of the mechanisms which 
might be in use (Slightom & Buchan, 2009). Long & Azam (2001) found that antagonistic activity 
is more common among particle-associated bacteria as compared to free-living bacteria, indicating 
that the production of antimicrobials could be involved in colonization of surfaces. In general, 
roseobacters show great potentials for production of antagonistic compounds (Bruhn et al., 2007; 
Martens et al., 2007), but only two antibacterial compounds have been characterized from members 
of the clade (Table 3.2): thryptanthrin produced by Oceanibulbus indoliflex and TDA which is 
detected from Ph. gallaeciensis, Ph. inhibens and R. mobilis. Slightom & Buchan (2009) also 
mentioned a correlation between a bipyridyl pigment and antagonistic behavior of Phaeobacter sp. 
strain Y4I. However, it is not clear if the antagonism is caused by the pigment or by another 
compound. 
Both Phaeobacter strain 27-4 and Ph. gallaeciensis strain SK2.10 colonize surfaces in in vitro 
models (Rao et al., 2005; Bruhn et al., 2006; Rao et al., 2006). Rao et al. (2005; 2006) showed that 
Ph. gallaeciensis strain SK2.10 effectively outcompete other marine bacteria including the strong 
biofilm-former, Pseudoalteromonas tunicata, on marine algae. Production of TDA is assumed to be 
the primary mechanism as TDA has been shown to cause an antagonistic effect of both Ph. 
gallaeciensis strain SK2.10 and Phaeobacter strain 27-4 (Bruhn et al., 2005; Gram et al., 2010). A 
great variety of bacteria originating from marine environments and bacteria known to cause 
diseases in fish and humans were all inhibited by crude cell cultures, washed cells, or supernatants 
from Ph. gallaeciensis, Ph. inhibens, R. mobilis or different Phaeobacter and Ruegeria strains in 
diffusion assays (Table 3.3). In this PhD study, strains randomly isolated from a turbot rearing 
facility were all inhibited by Phaeobacter and Ruegeria strains originating from the same facility 
(Porsby et al., 2008). Therefore, one should be aware that if such bacteria are deliberately added as 
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probiotic organism, they might not just inhibit the pathogenic agents, but could perhaps also alter 
the general microbiota. 
Table 3.2 Antagonistic compounds produced by Roseobacter clade members 
Roseobacter clade 
member Strain Origin 
Antagonistic 
compound Reference 
Oceanibulbus indoliflex HEL-45 North Sea Thryptanthrin (Wagner-Döbler et 
al., 2004) 
Phaeobacter gallaeciensis BS107 Scallop larvae culture Tropodithietic acid (Ruiz-Ponte et al., 
1998) 
Phaeobacter inhibens T5, M23-3.1 
etc. 
German Wadden Sea, 
Turbot rearing unit 
Tropodithietic acid (Brinkhoff et al., 
2004); (Porsby et al., 
2008) 
Phaeobacter sp. 27-4,  
M2-3.1etc. 
Turbot rearing units Tropodithietic acid (Hjelm et al., 2004a); 
(Porsby et al., 2008) 
Phaeobacter sp. Y4I Unknown Unknown (Slightom et al., 
2009) 
Ruegeria mobilis NBRC101030 
M43-2.3 
Marine biofilms, 
Turbot rearing unit 
Tropodithietic acid (Porsby et al., 2008); 
(Gram et al., 2010) 
Ruegeria sp. TM1040 Dinoflagellate Tropodithietic acid (Geng et al., 2008) 
D’Alvise et al. (2010) showed that the fish pathogenic bacteria Vibrio anguillarum strain 90-11-287 
was killed rapidly by Phaeobacter strain M23-3.1 (Figure 3.4). The effect was observed both when 
the Phaeobacter stain was applied attached to a peg and as suspended cells. Consistent with this, 
Phaeobacter strain 27-4 showed a killing effect and a mutant devoid of TDA production did not kill 
V. anguillarum strain 90-11-287, indicating that TDA caused the antagonistic effect. This study 
shows that the probiont might be added to an aquaculture system as attached bacteria on solid 
surfaces. 
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Table 3.3 Inhibition of various strains by Phaeobacter spp. and Ruegeria spp. determined by well diffusion assays 
using crude cell cultures, washed cells, or supernatants 
Target strain  Inhibited by Reference Target strain Inhibited by Reference 
Marine bacteria   Fish pathogens  4 
Erythromicrobium 
ramosum 
T5, BS107 1 Vibrio anguillarum M23-3.1, M43-2.3, 
PP-154, TM1040 
4, 5, 6 
Leisingeria 
methylohalidivorans 
T5, BS107 1 Vibrio vulnificus M23-3.1, M43-2.3, 
PP-154 
4, 5 
Colwellia maris T5, BS107 1 Vibrio splendidus M23-3.1, M43-2.3, 
PP-154 
4, 5 
Psychroserpens burtonenis T5, BS107 1 Vibrio harveyi M23-3.1, M43-2.3, 
PP-154 
4, 5 
Tenacibaculum T5, BS107 1 Vibrio aestuarianus PP-154 5 
Zobellia uliginosa T5, BS107 1 Vibrio alginolyticus PP-154 5 
Aeromicrobium fastidiosum T5, BS107 1 Vibrio fischeri PP-154 5 
Pseudonocardia alni T5, BS107 1 Vibrio fluvialis PP-154. 5 
Alteromonas marina SCH0407 2 Vibrio logei PP-154 5 
Shewanella oneidensis SCH0407 2 Vibrio mimicus PP-154 5 
Bacillus atrophaeus SCH0407 2 Vibrio 
parahaemolyticus 
PP-154 5 
Aquaculture isolates   Vibrio 
pelagiusproteolyticus 
PP-154 5 
Halomonas sp./Cobetia 
marina 
Phaeobacter spp. 
Ruegeria spp. 
3 Vibrio natriegens PP-154 5 
Microcuccus sp. Phaeobacter spp. 
Ruegeria spp. 
3 Vibrio neptunius PP-154 5 
Pseudomonas sp. Phaeobacter spp. 
Ruegeria spp. 
3 Vibrio tapetis PP-154 5 
Pseudoalteromonas sp. Phaeobacter spp. 
Ruegeria spp. 
3 Vibrio tubiashii PP-154 5 
Marinomonas sp. Phaeobacter spp. 
Ruegeria spp. 
3 Aeromonas salmonicida M23-3.1, M43-2.3, 
PP-154 
4, 5 
Rhodococcus sp. Phaeobacter spp. 3 Aeromonas hydrophila   
Olleya marilimosa Phaeobacter spp. 
Ruegeria spp. 
3 Tenacibaculum 
martimum 
M23-3.1, M43-2.3, 
PP-154 
4, 5 
Kordia algicida Phaeobacter spp. 
Ruegeria spp. 
3 Edwardsiella tarda PP-154 5 
Human pathogens  5 Pseudomonas 
anguilliseptica 
PP-154 5 
Bacillus subtilis T5 1 Lactococcus piscium M23-3.1, M43-2.3 4 
Staphylococcus aureus T5 1    
Escherichia coli T5 1    
1: (Brinkhoff et al., 2004); 2: (Bhattarai et al., 2006); 3: (Porsby et al., 2008); 4: (D'Alvise et al., 2010); 5: (Prado et al., 2009); 6: 
(Bruhn et al., 2007) 
T5: Phaeobacter inhibens; BS107 and SCH0407: Phaeobacter gallaeciensis; M23-3.1 and PP-154: Phaeobacter sp.; M43-2.3: 
Ruegeria mobilis; TM1040: Ruegeria sp. 
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Figure 3.4 Vibrio anguillarum strain 90-11-287 was exposed to 
Phaeobacter sp. strain M23-3.1 that was introduced as attached 
cells on pegs (a), or as suspended cells (b). Counts of V. anguillarum 
exposed to Phaeobacter in marine broth (MB) (T) and in Instant 
Ocean supplemented with glucose and amino acids (IO+) (V); 
negative controls were unexposed V. anguillarum in MB (S) and in 
IO+ (U). Growth of Phaeobacter was measured in the culture liquid 
(MB , IO+ ) and on the pegs (MB z, IO+ {). Points are 
averages of four determinations (duplicates in two independent 
trials) and error bars are standard deviation of the mean (D'Alvise 
et al., 2010) 
3.2 Conclusions from chapter 3 
Roseobacter clade members are strictly marine or hypersaline and they can be found in a variety of 
different marine environments both as culturable isolates and as non-culturable clones. The 
members are often associated different types of surfaces or particles which could indicate a strong 
preference for this lifestyle. The fact that some roseobacters are naturally occurring in many 
aquaculture settings, that they are easily culturable, and that Phaeobacter and Ruegeria strains have 
an antagonistic effect against a range of other bacteria make them promising probiotic candidates. 
The antagonistic effect of Phaeobacter and Ruegeria species is primarily due to production of 
TDA.
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4 Production of tropodithietic acid by Roseobacter clade strains 
Some Roseobacter clade members have an antibacterial effect, which is believed to be due to the 
secondary metabolite tropodithietic acid (TDA). It has been hypothesized that TDA causes the 
“disease reducing effect” when the probiont Phaeobacter strain 27-4 is added to turbot larvae 
infected with Vibrio (D'Alvise et al., 2010). Therefore, it is important from an applied point of view 
to elucidate both the nature of the antagonistic compound that causes the effect, and to understand 
how environmental and genetic factors influence TDA production. 
4.1 Tropodithietic acid 
Tropolones is a family of non-benzenoid aromatic compounds containing a seven-membered ring 
with a hydroxyl and a carbonyl group. Some derivates of this family have antagonistic effect against 
bacteria, viruses and fungi (Trust, 1975; Kintaka et al., 1984; Morita et al., 2002; Budihas et al., 
2005). TDA (Figure 4.1a) is such a derivate, and contains a disulfide bridge. It is likely to exist in a 
tautomeric form together with thiotropocin (Figure 4.1b) (Greer et al., 2008). TDA has a pKa value 
of 2 and is water soluble at neutral pH (7). The antibacterial activity of supernatant containing TDA 
from Phaeobacter strain 27-4 declined with increasing temperature. For example, no activity of the 
supernatant was detected after storage at 37°C for two days, whereas activity was stable at 5°C for 
up to eight days and for 3 months at -80ºC (Bruhn et al., 2005). 
 
Figure 4.1 Structure of the antibacterial 
compounds tropodithietic acid (a) and 
thiotropocin (b). Modified from (Thiel et 
al., 2010) 
Production of TDA is not a common feature of all Roseobacter clade members as the compound has 
only been detected from the species Phaeobacter gallaeciensis, Phaeobacter inhibens and Ruegeria 
mobilis. Silicibacter strain TM1040 also produces TDA, however, it is currently being discussed if 
the Silicibacter genus should be reclassified to the Ruegeria genus (the strain will in this thesis be 
named Ruegeria strain TM1040) (Brinkhoff et al., 2008; Newton et al., 2010). Other roseobacters 
such as Roseobacter denitrificans, Roseobacter litoralis, Roseovarius tolerans, Leisingera 
methylohalidivorans, Marinovum Agricola, Silicibacter pomeroyi and Sulfitobacter pontiacus do 
not produce this antibacterial compound (Gram et al., 2010; Geng & Belas, 2010). This is in 
agreement with Newton et al. 2010(#261) who only found genes for TDA biosynthesis in genomes 
a) b) 
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of Ruegeria strain TM1040, Ph. gallaeciensis strains SK2.10 and BS107, but not in 29 other 
genomes of Roseobacter clade members. 
TDA producing strains are also found outside the Roseobacter clade. A Pseudovibrio strain JE062 
isolated from a marine sponge also produce TDA, however, it belongs to the same order 
(Rhodobacterales) as roseobacters do (Geng et al., 2010). Thiotropocin (or TDA) is produced by a 
soil bacteria identified as Pseudomonas (strain CB-104) (Tsubotani et al., 1984; Kintaka et al., 
1984) and Caulobacter strain PK654 isolated from marine microalgae (Kawano et al., 1997; 
Kawano et al., 1998). It is likely that Caulobacter strain PK654 belongs to the genera Phaeobacter 
or Ruegeria as biochemical tests indicate this (Gram negative, nonfermentativ / nonoxidative, 
motile rods with positive catalase and oxidase reactions and they form brown colonies on marine 
agar). In addition, the GC content of the Caulobacter genus is normally 62-67 mol% (Holt et al., 
1994) but strain PK654 contains only 58 mol%, which is similar to the GC content of Ph. 
gallaeciensis (57.6-58 mol%) (Ruiz-Ponte et al., 1998). R. mobilis has a slightly higher GC content 
(58.5 mol%) (Muramatsu et al., 2007). Hence, strain PK654 may not be a new species within the 
genus Caulobacter as proposed by Kawano et al. (Kawano et al., 1997), but a Ph. gallaeciensis 
strain. 
4.2 Conditions facilitating production of tropodithietic acid 
Roseobacter clade strains do not produce TDA under all laboratory conditions but require specific 
environmental settings. A physical parameter such a shaking (aeration) is important for TDA 
production. For Phaeobacter strain 27-4 grown at stagnant conditions there is a positive correlation 
between production of brown pigment, formation of star-shaped aggregates (rosettes), ability to 
inhibit Vibrio anguillarum strain 90-11-287 and production of TDA (Figure 4.2 c and d) (Bruhn et 
al., 2005). However, none of these phenotypes appear if the strain is grown with shaking. Similar 
correlations have to the best of my knowledge not been reported for other tropolone compounds. 
However, production of pigment and antibacterial activity are only observed at stagnant conditions 
for Bacillus licheniformis strain EI-34-6 and not when grown with shaking (Yan et al., 2002; Yan et 
al., 2003). Yang et al. (2007) noticed a connection between growth in aggregates and production of 
the pigment violacein, which have antibacterial activity, as production was most pronounced at 
stagnant conditions. 
Separation of supernatant from Phaeobacter strain 27-4 into different fractions showed that the 
fraction containing TDA was antibacterial, whereas the brown pigment fraction had no activity. 
Therefore, the brown pigment and TDA are two different compounds but the pigment appears to be 
an indicator for presence of TDA when the culture is grown in marine broth. It is unknown what the 
brown pigment is but it could be a melanin compound as production of this pigment is known from 
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other bacteria (Ruan et al., 2003; Dastager et al., 2006; Huang et al., 2009). It can also be 
speculated if polymerization of TDA leads to the brown pigment as these two phenotypes co-occur 
(Bruhn et al., 2007). 
 
Figure 4.2 Cell morphology of and pigment formation by 
Roseobacter clade strains grown in marine broth under 
static (0 rpm) (a, c and e) or shaking (200 rpm) (b, d and 
f) conditions. The Danish Phaeobacter sp. strain M23-3.1 
(a and b), the Spanish Phaeobacter sp. strain 27-4 (c and 
d), and the Danish Ruegeria sp. strain M43-2.3 (e and f) 
are shown. Microscopy pictures are from phase-contrast 
microscopy at 1000x magnification. Bars, 10 µm (Porsby 
et al., 2008) 
 
Not all TDA producing roseobacters have this demanding physical requirement for production of 
TDA. The use of TDA producing roseobacters as fish larvae probiotics is the long term aim, and 
stringent stagnant conditions are not likely to be found in a fish tank. Work from this PhD study 
showed that all Phaeobacter strains isolated from Danish or Spanish turbot rearing facilities (except 
strain 27-4) display the mentioned phenotypes simultaneously both during shaking and stagnant 
conditions (Figure 4.2 a and b and Figure 4.3) (Porsby et al., 2008). However, the size of inhibition 
zones against V. anguillarum strain 90-11-287 in well diffusion assay and the amount of TDA 
produced are greatest at stagnant growth conditions. In contrast, all R. mobilis strains tested only 
produce brown pigment, grow in rosettes, inhibit V. anguillarum strain 90-11-287 and produce 
TDA when grown under stagnant conditions in marine broth (Figure 4.2 e and f and Figure 4.3). So 
interestingly, Phaeobacter strain 27-4 shows highest similarity to other Phaeobacter strains when 
comparing their 16S rRNA genes, but phenotypically it resembles R. mobilis strains. Ph. inhibens 
strain T5 also produce TDA under both growth conditions (Gram et al., 2010). 
The brown pigment and probably also TDA are mainly produced in the surface-media interface of 
the stagnant cultures of Phaeobacter strain 27-4 and R. mobilis. It can be hypothesized that 
requirements for specific atmosphere conditions e.g. oxygen concentrations causes this 
phenomenon, or that the strains have a preference for the surface tension found in this air-liquid 
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interface. However, either these hypotheses are not correct, or different species vary with regard to 
which conditions facilitate TDA production, as Ph. gallaeciensis and Ph. inhibens display these 
phenotypes both when grown at stagnant and shaken conditions. As this positive correlation 
between production of TDA, ability to grow in rosettes or aggregates and ability to attach to a 
surface exists (Figure 4.2 and Figure 4.3) (Bruhn et al., 2007), it can indicate that biofilm formation 
is an important issue. To investigate this correlation, it can be studied if TDA negative mutants also 
lost the ability to attach to a surface. It can also be speculated if TDA producing bacteria encode 
genes for surface proteins unique to this group of bacteria. This could perhaps be studied by 
comparing genomes of TDA producing bacteria (e.g. Ph. gallaeciensis strain BS107 and Ruegeria 
strain TM1040) to Sulfitobacter sp. strain EE-36 which at stagnant growth conditions form rosettes 
and attach very well to a surface (Bruhn et al., 2007) but do not produce TDA (Geng et al., 2010). 
 
Figure 4.3 Attachment (a), production of pigment (b), 
tropodithietic acid (c), and ability to inhibit Vibrio 
anguillarum strain 90-11-287 in well diffusion assay 
(d) of Roseobacter clade strains and V. anguillarum 
strain 90-11-287 grown under shaking (200 rpm) 
(black bars) or stagnant (0 rpm) (gray bars) 
conditions. The attachment assay was conducted in 
duplicates, and error bars represent standard 
deviations. Strains are grown in marine broth for 
three days. In the well diffusion assay, the diameter of 
the well itself has been subtracted from the diameter 
of the inhibition zone (Porsby et al., 2008) 
 
Temperature and marine salts also influence production of TDA in Phaeobacter strain 27-4 when 
grown in marine broth (Bruhn et al., 2005). Cultures incubated at 15 to 30°C produced the 
antibacterial compound, whereas 5, 10 and 37°C did not facilitate the production. Only minor 
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bacterial activity was detected from cultures grown in marine broth where insoluble compounds 
(salts) are removed. 
4.3 Biosynthesis of tropodithietic acid 
Secondary metabolites are all produced from a relatively small number of key intermediates. These 
arise from the primary metabolic pathways that are shared by all bacteria, namely the pathways for 
production or metabolism of primary metabolites i.e. carbohydrates, proteins, and nucleic acids. 
Example of such a key intermediate is shikimic acid, which can be used in the production of 
aromatic amino acids and other aromatic compounds (Mann, 1994). Both TDA and thiotropocin are 
aromatic compounds (Figure 4.1). Cane et al. (1992) showed that labeled glucose is converted into 
phenylacetic acid through shikimate by the shikimate-chorismate pathway, and the authors suggest 
two plausible routes to thiotropocin where phenylacetic acid is altered by oxidative ring expansion 
followed by further oxygen-sulfur exchange (Figure 4.4). The same pathways are identified by 
Thiel et al. (2010), however, they propose that a bound phenylacetyl-CoA substrate is more likely 
than a free phenylacetic acid. 
 
Figure 4.4 Proposed biosynthesis of thiotropocin. Shikimate (8) is converted into phenylacetic acid (12) via the 
shikimate-chorismate pathway, and phenylacetic acid (12) then undergoes oxidative ring expansion to 
thiotropocin (1a and 1b) (Cane et al., 1992) 
No studies have shown how the two sulfur atoms are added onto the TDA molecule, however, it has 
been speculated if dimethylsulphoniopropionate (DMSP) produced by algae in the oceans is the 
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source in natural environments (Bruhn et al., 2007; Geng et al., 2008; Geng et al., 2010). This is a 
possible source as TDA producing roseobacters contain genes involved in the utilization of DMSP 
(dmdA and dddP) (Newton et al., 2010). However, conflicting results are published as Geng et al. 
(2008) did not observe TDA production from Ruegeria strain TM1040 after addition of DMSP, 
whereas Geng & Belas (2010) found a two-fold increase by addition of DMSP. However, this does 
not explain why roseobacters produce TDA in laboratory media such marine broth (Bruhn et al., 
2005; Geng et al., 2008; Porsby et al., 2008) which does not contain DMSP. Hence, other sulfur 
sources can be used in the biosynthesis. Marine broth is rich in amino acids and sulfur, and Geng et 
al. (2008) demonstrated that addition of the amino acid cysteine as the only sulfur source induced 
TDA production. 
4.3.1 Genes involved in biosynthesis of tropodithietic acid 
Genes involved in TDA biosynthesis has been identified by random transposon insertion 
mutagenesis in Phaeobacter strain 27-4 and Ruegeria strain TM1040 (Table 4.1) (Geng et al., 
2008). The main analysis were carried out on Ruegeria strain TM1040 as this strain is genome 
sequenced, and this is probably why e.g. all the tdaA to tdaF genes (see later this section) is not 
identified in Phaeobacter strain 27-4. 
The only regulatory gene found among mutants lacking TDA production was tdaA, which has 
homology to LysR regulators (Geng et al., 2008). LysR regulatory proteins are global 
transcriptional regulators acting as either activators or repressors of single or operonic genes 
(Maddocks & Oyston, 2008). They regulate genes involved in e.g. cell division (Lu et al., 2007), 
motility (Lehnen et al., 2002), quorum sensing (Sperandio et al., 2002), virulence factors (Sheehan 
& Dorman, 1998) and sulfur utilization (Jovanovic et al., 2003). This indicates that biosynthesis of 
TDA at a transcriptional level is regulated by a LysR regulator homolog. 
The gene tdaA is a part of a gene organization, which includes the genes tdaA to tdaF, and it is 
present in both Ruegeria strain TM1040, Ph. gallaeciensis strain BS107 and SK2.10 and 
Pseudovibrio strain JE062 (Figure 4.5). In Ruegeria strain TM1040 these genes are localized on a 
plasmid. Searching the genomes of Ph. gallaeciensis strains the same organization of tdaA to tdaF 
were found, however, they were localized on the chromosome. Also, a partly assembled genome of 
R. mobilis strain F1926, which was isolated on a global research expedition (Gram et al., 2009; 
Gram et al., 2010), harbors this organization of tdaA to tdaF (unpublished data). From an applied 
point of view, it is an advantage that the genes involved in TDA production are located on the 
chromosome since loss of TDA production by spontaneous loss of the plasmid (Geng et al., 2008) 
will not occur. Spontaneous non-pigmented mutants which no longer had antibiotic activity were 
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also observed for Ph. inhibens strain T5 (Brinkhoff et al., 2004), indicating that perhaps genes 
involved in TDA production are localized on a plasmid in this strain. 
Table 4.1 Genes identified in biosynthesis of tropodithietic acid in Ruegeria strain TM1040 and Phaeobacter 
strain 27-4. Modified from (Geng et al., 2008) 
Function Ruegeria strain TM1040  Phaeobacter strain 27-4 
 Gene Function  Gene Function 
Ring precursor, oxidation,  paaK Phenylacetate oxidoreductase    
and expansion paaI Phenylacetate oxygenase    
 paaJ Phenylacetate oxygenase    
 tdaD 4-Hydroxybenzoyl-CoA 
thioesterase 
   
 tdaE Acyl-CoA dehydrogenase    
 tdaB Beta-etherase  tdaB Beta-etherase 
 tdaC Prephenate dehydratase    
Sulfur metabolism and 
addition 
malY C-S lyase (cystathionase);  
Amino transferase 
   
 tdaH Sulfite oxidase domain protein    
 cysI Sulfite reductase    
    metF 5-Methyltetrahydrofolate– 
Homocysteine; S-methyltransferase 
CoA metabolism tdaF Phosphopantothenoylcysteine 
decarboxylase 
   
    tdbA D-β-Hydroxybutyrate 
dehydrogenase 
    tdbB Phosphate acetyltransferase 
    tdbC Lytic transglycosylase, 
peptidase C14 
    traI TraI, type IV (Vir-like) 
secretion 
    tdbD Type I secretion target 
repeat protein 
    tdbE Oligopeptide/dipeptide ABC 
transporter 
      
Regulatory mechanism tdaA LysR substrate-binding 
domain protein 
 tdaA LysR substrate-binding 
domain protein 
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Figure 4.5 Arrangement of the genes tdaA to tdaF involved in production of tropodithietic acid in Ruegeria strain 
TM1040, Phaeobacter gallaeciensis strain BS107 and SK2.10 and Pseudovibrio strain JE062.  indicates a break 
in the region. Modified from (Geng et al., 2010) 
Due to the arrangement of the tdaA to tdaF genes in Ruegeria strain TM1040, one could 
hypothesize that tdaA regulates tdaB to tdaF. Geng & Belas (2010) indicates that tdaA and tdaB are 
arranged in an operon and that tdaCDE constitute a separate operon. The gene organization 
indicates that the tdaF gene forms a putative operon with the gene next to it, as there are only 35 
nucleotides between them. This gene is a metabolism gene encoding an aldehyde dehydrogenase. 
Under stagnant growth conditions, which facilitates TDA production in Ruegeria strain TM1040, 
tdaA is expressed constitutively whereas the amount of tdaCDE and tdaF RNA increase 
significantly as compared to conditions where TDA is not being produced (shaking) (Geng et al., 
2010). Also, in nine of 11 TDA negative mutants the ability to transcribe tdaC is restored by 
placing TDA producing strains in their proximity or by addition of exogenous TDA. The authors 
suggest that TDA (or a late-stage chemical intermediate in TDA biosynthesis) induce tda gene 
expression and that the compound functions as an autoinducer of its own synthesis (Geng et al., 
2010). 
Attempts were made in this PhD study to use Nothern blot to reveal the gene organization of tdaA 
to tdaF in Ph. gallaeciensis strain BS107 and Ruegeria strain F1926, and to quantify gene 
expression of tdaB in the same two strains using quantitative-Real-Time-PCR. However, the 
methods did not work – probably due to low expression levels of the genes. Another obstacle was to 
obtain good quality and quantity RNA from those two bacteria, and several RNA purification kits 
and growth media were tried out. 
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4.4 Conclusions from chapter 4 
The antibacterial compound TDA is only produced by Ph. gallaeciensis, Ph. inhibens, R. mobilis, 
thus, this is not a phenotype defining all Roseobacter clade members. Ph. gallaeciensis and Ph. 
inhibens strains produce TDA both when grow at stagnant and shaking conditions, whereas R. 
mobilis and Phaeobacter strain 27-4 only produce the antagonistic compound at shaking conditions. 
This versatility of Phaeobacter strains (except strain 27-4) makes them interesting in an applied 
perspective as only a few sites in a fish tank will be stagnant, and it is believed that this group will 
have probiotic effect in aquaculture settings due to TDA production. Therefore, it is important to 
gain knowledge about e.g. which bacteria are sensitive to TDA and what the mechanism-of-action 
of TDA against other bacteria is (chapter 5). The biosynthesis pathway of TDA is not fully known, 
but the compound is probably biosynthesized from phenylacetyl-CoA by oxidative ring expansion 
and oxygen-sulfur exchange. However, the exact way the sulfur atoms is added to the molecule is 
not identified. The sulfur source for TDA production includes e.g. cysteine (at least for Ruegeria 
strain TM1040) whereas the algal product DMSP is a more questionable source under laboratory 
conditions.
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5 Tropodithietic acid as an antimicrobial compound 
It is believed that the fish probiotic effect caused by Roseobacter clade strains is due to production 
of the antagonistic compound tropodithietic acid (TDA) (Bruhn et al., 2005; D'Alvise et al., 2010). 
To use TDA producing strains as probionts it is important to understand the response of the target 
bacteria when exposed to TDA or the probiotic bacteria. So far, resistance to novel antibiotics has 
developed within a couple of years after introduction (Figure 5.1) (Clatworthy et al., 2007). It is 
therefore a key issue in the use of TDA producing probiotic bacteria, to address if target bacteria 
develop resistance to TDA. 
 
Figure 5.1 Timeline of antibiotic development and the evolution of resistance. The year each antibiotic was 
developed is depicted above the timeline, and the year resistance to each antibiotic was observed is depicted 
below the timeline (with the caveat that the appearance of antibiotic resistance does not necessarily imply that a 
given antibiotic has lost all clinical utility) (Clatworthy et al., 2007) 
The topic of antimicrobial targets and resistance mechanisms is an enormous area and it is not the 
intention in this thesis to cover it all. During this PhD study, I made repeated attempts to generate 
TDA resistant mutants, however, this was not possible. This led to an interest in the mechanism-of-
action of TDA, and whilst the thesis work does give indications of this, the precise target was not 
identified. Therefore, the purpose of this chapter is to give a very brief introduction to the antibiotic 
field including antimicrobial peptide and biocides to present an overview of targets and resistance 
mechanisms. This knowledge and the experimental results that exist for TDA are combined in order 
to present a hypothesis on the mechanism-of-action of TDA. 
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5.1 Bacterial targets for antibiotics and other antimicrobials 
Different antimicrobials can be used for combating bacteria and includes antibiotics, antimicrobial 
peptides and biocides. They differ in the way they are used and in their mechanism-of-action as 
described in the following sections. Most attention in this thesis has been given to antimicrobial 
peptides and biocides since preliminary experiments indicated that the activity TDA could be 
contributed to mechanisms resembling those two groups. TDA probably target the bacterial cell 
envelope, which is also the case for antimicrobial peptides. Due to difficulties getting resistant or 
tolerant strains, TDA could have multiple target sites like biocides. 
5.1.1 Mechanism­of­action of antibiotics 
Antibiotics are either natural products or synthetic chemicals used for treatment of bacterial 
infections in a host. They can also be used preventively in animal flocks for prophylaxis, as therapy 
for sick animals combined with prophylaxis in healthy individuals (metaphylaxis), and as growth 
promoters using the antibiotic at sub-therapeutic concentrations to increase body growth of the 
animal. The latter application is banned in countries within the European Union, however, it is still 
used in the US and Australia (Guardabassi et al., 2006). 
Antibiotics work by inhibition of biochemical pathways that are involved in biosynthesis of vital 
components in a bacterial cell, and the antibiotic attack a single biochemical target that is not 
present in the host. The major targets of antibiotics are (i) cell wall biosynthesis, (ii) protein 
biosynthesis, (iii) DNA replication and repair, and (iv) folate coenzyme biosynthesis (Figure 5.2) 
(Walsh, 2003b). 
 
Figure 5.2 Major bacterial targets 
for antibiotics (Walsh, 2003b) 
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5.1.2 Mechanism­of­action of antimicrobial peptides  
Antimicrobial peptides represent an evolutionary well-conserved group of bacterial inactivator 
molecules, and they are widespread in the innate immune systems of fungi, plants, insects and 
mammals (Yeaman & Yount, 2003). Five major classes of antimicrobial peptides exist: (i) anionic 
peptides, (ii) linear cationic α-helical peptides, (iii) cationic peptides enriched for specific amino 
acids (proline, glycine, histidine and tryptophan), (iv) anionic and cationic peptides containing 
cystein that form disulphide bonds, and (v) anionic and cationic peptide fragments of larger proteins 
(Brogden, 2005). Antimicrobial peptides have two possible applications in therapy. They can be 
used as direct antimicrobial agents due to their broad antibacterial spectrum and rapid action, or as 
immunomodulatory compounds in a new therapeutic approach as they stimulate the innate immune 
system (Hancock & Sahl, 2006). 
Antimicrobial peptides excert their effect via several mechanisms. They attack many different 
microbial targets at the same time but with modest potency instead of blocking a specific high-
affinity target (Peschel & Sahl, 2006). It is generally accepted that most antimicrobial peptides 
cause destabilization of the bacterial cell membrane exemplified by the Shai-Matsuzaki model 
(Figure 5.3). The peptide interacts with the membrane, followed by displacement of lipids and 
alteration of membrane structure and even collapse of the membrane (Zasloff, 2002). 
Furthermore, formation of pores seems to be a central point in the peptide-membrane interaction. 
Pores allow passage of ions and small molecules, which lowers of proton gradient and destroy the 
membrane potential, stop ATP production and all cellular metabolism, finally leading to cell death 
(Huang, 2000). Some antimicrobial peptides also have intracellular targets (Table 5.1), e.g 
indolicidin and pleurocidin inhibit DNA synthesis and protein synthesis, respectively, 
(Subbalakshmi & Sitaram, 1998; Patrzykat et al., 2002). In addition to the antimicrobial effect, 
some peptides also stimulate the immune system by boosting both innate and adaptive immune 
response which favours resolution of infections (Lai & Gallo, 2009). Hench, they are also referred 
to as host defence peptides. 
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Figure 5.3 The Shai-Matsuzaki model for the mechanism of action of an antimicrobial peptide. An α-helical 
peptide is depicted. (a) Carpeting of the outer leaflet with peptides. (b) Integration of the peptide into the 
membrane and thinning of the outer leaflet. The surface area of the outer leaflet expands relative to the inner 
leaflet, resulting in strain within the bilayer (jagged arrows). (c) Phase transition and ‘wormhole’ formation. 
Transient pores form at this stage. (d) Transport of lipids and peptides into the inner leaflet. (e) Diffusion of 
peptides onto intracellular targets (in some cases). (f) Collapse of the membrane into fragments and physical 
disruption of the target cell’s membrane. Lipids with yellow headgroup are acids, or negatively charged. Lipids 
with black headgroups have no net charge (Zasloff, 2002) 
 
Table 5.1 Membrane and intracellular models of antimicrobial peptide killing and lysis. Modified from 
(Brogden, 2005) 
Mode of intracellular killing Examples of peptides 
Flocculation of intracellular content Anionic peptides 
Alters cytoplasmic membrane septum formation PR-39, PR-26, indolicidin, microcin 
Inhibits cell wall synthesis Mersacidin 
Binds nucleic acids Buforin II, tachyplesin 
Inhibits nucleic acid synthesis Pleurocidin, dermaseptin, PR-39, HNP-1, HNP-2, indolicidin 
Inhibits protein synthesis Pleurocidin, dermaseptin, PR-39, HNP-1, HNP-2, indolicidin 
Inhibits enzyme activity Histatins, pyrrhocoricin, drosocin, apidaecin 
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5.1.3 Mechanism­of­action of biocides 
Biocides include chemicals (inorganic or synthetic organic molecules) with antiseptic, disinfectant 
and/or preservative activity (Chapman, 2003). They can be used for a variety of purposes on 
inorganic objects (hard surface disinfectants), externally on the skin to prevent or limit microbial 
infection (antiseptics and topical antimicrobials), for skin disinfection previous to operations or 
incorporated into pharmaceutical, cosmetics or other types of products (preservatives) to prevent 
microbial contamination (Russell, 2003). Often a product contains more than one biocide or active 
component. 
In contrast to antibiotics, biocides generally act on a number of distinct targets with varied 
susceptibilities and the target may also occur in eukaryotic organisms (Gilbert et al., 2002). One 
exception from this is triclosan (used in household products like toothpaste and soap) which inhibits 
the fabI gene encoding the enoyl-acyl carrier protein reductase of fatty acid biosynthesis (McMurry 
et al., 1998). Biocides can be divided into four groups based on their mechanism-of-action (Table 
5.2). 
Table 5.2 Mechanisms-of-actions of biocides. Modified from (Chapman, 2003) 
Mechanism-of-action Group Example of biocide 
Electrophile biocides Oxidants Halogens 
  Peroxy compounds 
 Electrophils Formaldehyde 
  Isothiazolones 
  Bronopol 
  Inorganic ions (Cu, Hg, Ag) 
Membrane active biocides Lytic Quaternary ammonium compounds 
  Biguanides 
  Phenols 
  Alcohols 
 Protonophores Parabens 
  Weak acids 
  Pyrithione 
Oxidants work directly via radical-mediated reactions to oxidize organic material (Clapp et al., 
1994; Dukan & Touati, 1996; Dukan et al., 1999). Electrophils react covalently with cellular 
nucleophiles to inactivate enzymes and they might form intracellular free radicals which contribute 
to the lethal action (Collier et al., 1990; Kimura & Nishioka, 1997). Lytic compounds cause 
destabilization of the bacterial membranes leading to cell lysis (Gilbert et al., 1977; Chawner & 
Gilbert, 1989). Protonophores interfere with the ability of the cell membrane to maintain a proper 
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pH balance within the cell resulting in acidification of the interior and disruption of metabolism 
(Eklund, 1985). 
5.1.4 How to study mechanisms­of­actions of antimicrobials 
There are no “golden rules” describing how to study the mechanism-of-action of antimicrobials 
against bacteria, but such studies are normally initiated using basic microbiological analyses. 
Initially the spectrum of target organisms is often evaluated e.g. does it work against all bacteria 
(broad spectrum) or only some groups of bacteria (narrow spectrum). Then it is investigated if the 
compound is bacteriostatic or bactericidal to bacterial cell. Also, it is relevant to study if an 
antimicrobial agent causes disruption of the cytoplasmic membrane, which is often exemplified by 
leakage of intracellular components such as ATP, potassium, inorganic phosphate and materials 
absorbing at 260 nm (e.g pyrimidines and purines) (Lambert & Hammond, 1973; Ultee et al., 2002; 
Raafat et al., 2008; Gottlieb et al., 2008; Nobmann et al., 2010; Schneider et al., 2010a). Electron 
microscopy can reveal if a compound causes visible damage to cells such as elongation or other 
shape malformations, membrane damage or complete lysis (Collier et al., 1990; Bizani et al., 2005; 
Raafat et al., 2008). 
The effect of antimicrobials on macromolecules can be studied by analyzing the incorporation of 
radioactive labeled precursors into cellular macromolecules while they are synthesized. For 
example isoleucin and histidies are incorporated into proteins, thymidine and uridine into nucleic 
acid, and glucoseamine are building blocks in synthesis of peptidoglycane (Patrzykat et al., 2002; 
Schneider et al., 2010a). Lack of such incorporation upon antimicrobial treatment point to a target 
in a biosynthetic pathway. 
Bacterial cells express different genes as a result of environmental stimuli. By comparing gene 
expression patterns between bacteria exposed and not exposed to an antimicrobial compound, it 
may be possible to point at genes involved in the response and hence, potentially, to the 
mechanism-of-action of the drug. Transcriptomic analyses have been used to determine gene 
expression upon antimicrobial exposure  (Hansen et al., 2004; Brazas & Hancock, 2005; Raafat et 
al., 2008; Jang et al., 2008; O'Donnell et al., 2009; Schneider et al., 2010a), however, it can only be 
used on bacteria where commercial chips exist or on genome sequenced strains where custom made 
microarray chips can be prepared. These limitations in choice of strain can be circumvented by 
using e.g. RNA-Arbitrarily-Primed-PCR (Holmstrøm et al., 2003; Papadimitriou et al., 2008), 
however, this more limited analysis will not give the full picture of all genes. New sequencing 
methods such as 454 are not restricted to genome sequenced strains. 
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An alternative approach to reveal target(s) of an antibiotic include the use of biosensors, however, 
this method has not been published. The method is based on natural stress responses of bacteria to 
perturbation. These responses result in activation of specific genes which are monitored using 
reporter genes labeled with e.g. GFP variants. Thereby, the set of biosensors employed emit 
fluorescence of different wavelengths depending on the mode of the perturbation. Selective cell 
wall, ribosome and fatty acid biosynthesis can be identified as target of drugs in bacteria using this 
method (Dirk Bumann, University of Basel, personal communication). 
5.1.5 Mechanism­of­action of tropodithietic acid 
It is important from an applied point of view to know, which bacteria are affected by TDA and the 
mechanism-of-action of the compound. This understanding is required to determine e.g. the 
spectrum of use and to evaluate application possibilities. A collection of human pathogenic bacteria 
of both Gram-negative and Gram-positive bacteria were inhibited by TDA when determining the 
minimum inhibitory concentration (MIC) (Table 5.3). However, Gram-negative organisms were 
less sensitive to TDA as compared to Gram-positive bacteria. Other studies have also seen this 
broad-spectrum effect of thiotropocin (or TDA) for different human pathogens (Tsubotani et al., 
1984; Kintaka et al., 1984). 
The difference in sensitivity between Gram-negative and Gram-positive bacteria could be due to the 
different cell wall, assuming that the outer membrane of Gram-negative organisms could provide a 
protective shield against TDA. This is supported by the fact that only Gram-negative bacteria have 
increased sensitivity to TDA after treatment with EDTA (Porsby et al., 2010). It has been reported 
that less thiotropocin (or TDA) is needed in order to reach the MIC value for a variety of different 
human pathogenic bacteria at low pH (Tsubotani et al., 1984; Kintaka et al., 1984). An explanation 
for this effect could be that the equilibrium of TDA at low pH values is moved to the protonated 
state resulting in a more lipophilic compound, which can more easily penetrate the outer membrane 
of Gram-negative bacteria as compared to the non-protonated form. However, this theory does not 
explain why the pH effect is also seen for Gram-positive organisms lacking the outer membrane. 
Similarly, Manson et al. (2006) found that a cationic peptide LAH4 only had bacteriolytic effect at 
acidic pH and not at neutral pH. 
TDA is bactericidal against Vibrio anguillarum strain 90-11-287 (D'Alvise et al., 2010). In this 
thesis work, similar observations have been found for both Salmonella enterica serovar 
Typhimurium (hereafter referred to as Salmonella Typhimurium) strain SL1344 and Staphylococcus 
aureus NCTC 12493 in both growth medium (LB broth) and in buffer (PBS) (Figure 5.4). TDA 
therefore has an effect on both growing and non-growing cells. 
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Table 5.3 MIC values (mg/l) of tropodithietic acid determined in LB broth. MIC values were determined in two 
independent experiments and if all gave the same value, this is stated in the table. For some strains, MIC varied 
a factor of two between experiments as indicated (Porsby et al., 2010) 
Gram Species Strain MIC (mg/l) 
Negative Salmonella Typhimurium SL1344 (wildtype) 625 
 Salmonella Typhimurium SL1344 (ompF::aph) 625 
 Salmonella Typhimurium SL1344 (ompC::aph) 625 
 Salmonella Typhimurium ATCC 14028s (wildtype) 625 
 Salmonella Typhimurium ATCC 14028s (ΔtolC::CmR) 625 - 1250 
 Salmonella Typhimurium ATCC 14028s (ΔacrB::KmR) 625 - 1250 
 Salmonella Typhimurium ATCC 14028s (ΔacrAB::CmR) 625 - 1250 
 Salmonella Typhimurium ATCC 14028s (ΔacrD::CmR) 625 - 1250 
 Salmonella Typhimurium ATCC 14028s (ΔacrEF::CmR) 625 - 1250 
 Salmonella Typhimurium ATCC 14028s (ΔmdtABC::CmR) 625 - 1250 
 Salmonella Typhimurium ATCC 14028s (ΔmdsABC::CmR) 625 - 1250 
 Salmonella Typhimurium ATCC 14028s (ΔermAB::CmR) 625 
 Salmonella Typhimurium ATCC 14028s (ΔmdfA::CmR) 625 
 Salmonella Typhimurium ATCC 14028s (ΔmdtK::CmR) 625 - 1250 
 Salmonella Typhimurium ATCC 14028s (ΔmacAB::CmR) 625 
 Salmonella Typhimurium L3 (Human  pre-therapy clinical isolate) 625 - 1250 
 Salmonella Typhimurium L10 (Human  post-therapy clinical isolate, acrAB+++) 625 - 1250 
 Enterobacter cloacae NCTC 10005 625 - 1250 
 Serratia marcescens NCTC 2847 625 - 1250 
 Klebsiella pneumoniae NCTC 10896 625 - 1250 
 Klebsiella pneumoniae NCTC 9633 625 
 Escherichia coli NCTC 10538 (K12) 155  - 625 
 Morganella morganii NCTC 235 155 
 Pseudomonas aeruginosa NCTC 10662 625 
 Vibrio anguillarum 90-11-287 (from rainbow trout) 40 - 80 
 Phaeobacter ssp. 27-4 (from Spanish turbot unit) (wildtype) 310 
 Phaeobacter ssp. JBB1001 (tdaB::EZ-Tn5,Kan) 155 
Positive Staphylococcus aureus NCTC 8532 (MSSA) 155 
 Staphylococcus aureus NCTC 12493 (MRSA) 155 
 Enterococcus faecalis NCTC 775 80 
 Enterococcus faecalis NCTC 7171 80 
 Listeria monocytogenes NC12427 80 
Salmonella Typhimurium: Salmonella enterica serovar Typhimurium 
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Figure 5.4 Killing kinetics of tropodithietic acid (TDA) on Salmonella enteric serovar Typhimurium strain 
SL1344 (A and C) and Staphylococcus aureus stain NCTC 12493 (B and D) in LB medium (A and B) and in 
phosphate buffered saline (C and D). The following concentrations of TDA were used: MIC ( ), ½MIC ( ), 
¼MIC ( ) and a growth control containing no TDA ( ). Counts are mean of duplicates and error bars represent 
standard deviations. Arrows indicate observations below detection limit (Porsby et al., 2010) 
Salmonella Typhimurium mutants with non-functional porins or efflux pumps were approximately 
as sensitive to TDA as their parent strains (Table 5.3). This indicates that these structures are not 
involved in the innate resistance to TDA in Salmonella Typhimurium. Also, TDA does not cause 
any visible damage to Escherichia coli strain K12 cells (Figure 5.5). Kintaka et al. (1984) did not 
see morphological changes to Proteus mirabellis IFO 3168, but very poor lysis was observed in E. 
coli NIHJ JC2 after exposure to high concentrations of the tautomeric form of TDA, thiotropocin. 
Keeping in mind that TDA works very well on non-growing cells these results could collectively 
indicate that TDA does not have to enter the interior of a bacterial cell, i.e. TDA does not have to 
cross the cell wall or the membrane, in order to exert its effect. It is therefore plausible that TDA 
targets the cell envelope, and it must be a component that both Gram-positive and Gram-negative 
bacteria have in common as TDA is antibacterial against both groups. Consequently, it is in this 
thesis suggested that TDA targets either the peptidoglycan or the cytoplasmic membrane. The target 
of TDA in Salmonella Typhimurium has been studied using a biosensor approach (see section 
5.1.4), and the results indicate that the cell envelope and perhaps the peptidoglycan structure is the 
target (Dirk Bumann, University of Basel, personal communication). 
C 
A B 
D 
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Figure 5.5 Transmission electron microsgraphs of Escherichia coli strain K12 treated (A and C) and not treated 
with (B and D) tropodithietic acid. Magnification: 150,000x (A and B) and 20,000x (C and D). Porsby, 
unpublished data 
The cell wall including the peptidoglycan posses well known targets for antibiotics. There are three 
main phases in cell wall biosynthesis which all are targets for antibiotics (van Heijenoort, 
2001(#379)): 
 First phase (cytoplasmic phase): The structural unit of peptidoglycan layers, muramyl 
pentapeptide, is synthesized in the cytoplasma 
 Second phase (membrane-associated phase): Muramyl pentapeptide is bound to the 
cytoplasmic surface of the cell membrane and translocated to its external face through 
formation of two lipid intermediates 
 Third phase (extracytoplasmic phase): Glycine and peptide strands of muramyl pentapeptide 
are cross-linked by membrane-bound transglycolase and transpeptidase, respectively 
The beta-lactams (e.g. penicillin, cephalosporin, carbapenems, and monobactams) is effective 
against both Gram-positive and Gram-negative bacteria and exert its effect on the third phase. 
These antibiotics contain a beta-lactam ring which is recognized by the active site of penicillin-
binding proteins involved in crosslinking glycan chains through transpeptidase reactions or removal 
of excess terminal D-alanine after completion of the crosslinking process (Schneider & Sahl, 
2010b). Antibiotics that act on the second phase in the cell wall synthesis include the group 
glycopeptide (e.g. vancomycin and teicoplanin). They cannot penetrate the pores in the outer 
A B
C D
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membrane of Gram-negative bacteria and are therefore only active against Gram-positive organisms 
(Walsh, 2003a). The activity of glycopeptides are due to binding of the antibiotic to the D-alanine-
D-alanine terminus of the peptide side chain of lipid II (Schneider et al., 2010b). This prevents 
incorporation of the D-alanine-D-alanine terminus into growing peptidoglycan. The first phase in 
the synthesis is inhibited by the antibiotic D-cycloserine by inhibition of the enzymes alanine 
racemate and D-alanine-D-alanine ligase which is involved in incorporation of alanine into cell wall 
precursors (Lambert & Neuhaus, 1972). It is unknown, which of the three steps in the biosynthesis 
of peptidoglycan that TDA targets. 
As part of this PhD study, a series of microarray experiments on Salmonella Typhimurium strain 
SL1344 exposed to TDA were conducted, however, I am currently waiting for the results. This 
expression study could indicate which genes are affected by TDA exposure, and hence, potentially 
point to the mechanisms-of-action. 
5.2 Antimicrobial resistance and tolerance 
Resistance in bacteria against virtually all antibiotics have been seen within years of usage 
(Clatworthy et al., 2007), and different mechanisms depending on the type of antibiotic have been 
developed. Lately, the term “tolerance” to a drug has been introduced which also describes the 
ability of a cell to withstand otherwise lethal concentrations of a antibiotic. However, tolerance does 
not involve genetic changes in the bacteria (Lewis, 2007). 
5.2.1 Definition of resistance and tolerance 
Resistance is a relative term mainly used for antibiotics. According to the microbiological 
definition, a strain is considered resistant if it grows in the presence of higher concentrations of the 
antibiotic as compared to phylogenetically related strains. On the other hand, a strain is considered 
clinically resistant if it survives antimicrobial therapy (Guardabassi et al., 2006). Determining the 
MIC value is one way to investigate if a strain is resistant, intermediate or susceptible to a 
antibiotic. The MIC value is the lowest concentration of an antibiotic that under in vitro conditions 
inhibits visible growth of the bacteria within a defined period of time (Andrews, 2001; Andrews, 
2006). To determine if a strain is resistant, the MIC value has to be compared to either 
microbiological or clinical breakpoints. Microbiological breakpoints are based on the MIC 
distribution for a bacterial species, while clinical breakpoints are not only considering the MIC 
distribution for a species but also in vivo parameters such as bacterial distribution in the host, and 
pharmacokinetics and pharmadynamics of the drug (Guardabassi et al., 2006). The clinical dose of 
antibiotic are near the MIC value, and resistant strains will therefore lead to treatment failure of the 
bacterial infection. 
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Many articles and reviews deal with the topic of resistance to antimicrobial peptides, but I have not 
been able to find a definition of resistance to antimicrobial peptides. However, keeping in mind that 
they are to be used as direct antimicrobials agents for combating infections, the same definitions 
and reflections as for antibiotics (microbiological and clinical) can be proposed for antimicrobial 
peptides. 
In respect to biocides, the term resistance is not well-defined. The definition proposed by Russell 
(2003) resembles the microbiological definition for antibiotics: “A culture is considered to be 
resistant to a biocide when it is not inactivated by an in-use concentration of biocide, or a biocide 
concentration that inactivates other strains of that organism”. On the other hand, Chapman (2003) 
use the MIC value to define resistance as “a measurable increase in the MIC value, often by a 
factor of 4 – 16-fold”. If using a MIC based definition, one should bear in mind that the in-use 
concentration of e.g. disinfectants is much higher that the MIC value, therefore, a resistant strain 
will probably not survive the disinfectant process (Bloomfield, 2002).  
A stage between susceptible and resistant exists for antibiotics where a strain can tolerate increased 
concentrations of the antibiotic but not as high concentrations as if the same strain had developed 
resistance. Lewis (2007) defined tolerance as “the ability of cells to survive killing by antibiotics 
without expressing or using resistance mechanisms”. A similar stage is likely also to exist for 
antimicrobial peptides and biocides. 
5.2.2 Resistance mechanisms for antibiotics 
Bacteria have many different mechanisms to overcome the effect of antibiotics (Table 5.4). Most 
common are enzymatic drug inactivation, modification or replacement of drug target, efflux of drug 
using pumps, and reduced drug uptake. Protection of target and drug trapping are not as common. 
Resistance to antibiotics can be divided into intrinsic and acquired resistance (Guardabassi et al., 
2006). Intrinsic resistance is caused by a structural or functional trait which gives all members of a 
bacterial group resistance against a particular drug or a class of antibiotics. An example is the 
resistance of Gram-negative bacteria to glycopeptides (e.g. vancomycin and teicoplanin) as the drug 
cannot penetrate the outer membrane (Schneider et al., 2010b). Acquired resistance is only 
associated with some strains within a genus or species, and it is due to a genetic change in the 
bacterial DNA caused by either a mutation or horizontal acquisition of foreign genetic material. For 
example chromosomally acquired streptomycin resistance is frequently due to mutations in the gene 
rpsL encoding the ribosomal protein S12 (Nair et al., 1993; Honoré & Cole, 1994; Olkkola et al., 
2010), whereas resistance to methicillin is associated with acquisition of a SCCmec mobile genetic 
element, which contains the mecA resistance gene (Okuma et al., 2002). Acquired resistance is 
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heritable due to multiplication of bacterial cells, and the resistance will be carried on to the next 
generations. 
Table 5.4 Mechanisms of bacteria leading to resistance against antibiotics 
Mechanism of resistance Effect Example of drug Reference 
Enzymatic drug 
inactivation 
Modify active nucleus of drug 
leading to inability of drug to bind 
to target site 
Beta-lactams 
Aminoglycoside 
(Knox et al., 1996) 
(Jana & Deb, 2006) 
Modification or 
replacement of drug target 
Target is structurally modified or 
replaced so drug can not bind 
Glycopeptides 
Quinolones 
MLS 
(Al-Obeid et al., 1990) 
(Jalal & Wretlind, 1998) 
(Pernodet et al., 1996) 
Efflux pumps Reduced concentration of drug in 
cytoplasm 
Tetracyclines 
Ciprofloxacin 
(Li et al., 1994) 
(Piddock et al., 2000) 
Reduced drug uptake Loss, reduced size, or decreased 
expression of porins leading to less 
drug inside the cell 
Beta-lactams 
Fluoroquinolones 
(Pages et al., 2009) 
(Danilchanka et al., 2008) 
Target protection RPPs bind to ribosomes in 
proximity to drug binding site and 
together with conformational 
changes drug can not bind 
Tetracyclines (Connell et al., 2003) 
Drug trapping Increased production of drug target 
or another molecule with affinity 
for drug leading to reduction of free 
drug at target site 
Vancomycin (Cui et al., 2000) 
MLS: Macrolide-lincosamide-streptogramin type B RPPs: Ribosomal protection proteins 
5.2.3 Tolerance to antimicrobials 
Tolerance is another way to evade the effect of antimicrobials as bacteria can develop tolerance to 
antibiotics, antimicrobial peptides and biocides by adapting to harsh conditions which might 
otherwise kill them. Tolerance is a temporary state, and it is not due to mutations or acquisition of 
external DNA as it is the case for ‘traditional’ antibiotic resistance. More likely it is a transient 
change in gene expression which provokes a physiological state resulting in the ability to tolerate 
and survive otherwise harmful concentrations of the drug or compound (Miller et al., 2004). 
Therefore, tolerance is a non-heritable phenotype.  
The phenomenon of persister cells is an example of phenotypic heterogeneity where a bacterial 
population do not act uniformly. When the population is treated with antibiotic, a small fraction of 
bacteria survives and when the antibiotic is removed, these cells re-grow as a new population that is 
just as sensitive to the antibiotic (Bigger, 1944; Lewis, 2007; Gefen & Balaban, 2009). This 
reversible tolerance has even been called “a phenotypic switch” (Balaban et al., 2004). Very little 
knowledge exists on the molecular mechanism underlying this tolerance, however, the hipA gene, 
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which may encoded a toxin protein that promote dormancy, is known to be involved in 
development of persister cells in E. coli (Moyed & Bertrand, 1983; Schumacher et al., 2009). 
5.2.4 Lack of resistance and tolerance to tropodithietic acid 
If TDA producing bacteria are to be used in aquaculture it is important to evaluate if resistance or 
tolerance can evolve. A collection of human and fish pathogens strains (Table 5.3 page 44, 
excluding the mutants) were exposed to purified TDA (Porsby et al., 2010). A range of different 
methods were applied in order to select for resistant mutants including single exposure to TDA 
administered via different methods. However, no TDA resistant mutants were selected. Tolerant 
strains were selected by multiple exposures to subinhibitory concentrations of TDA. The approach 
has proven especially successful for antimicrobial peptides and biocides (Méchin et al., 1999; Suller 
& Russell, 1999; Perron et al., 2006; Karatzas et al., 2007), and it resulted in two-fold increased 
MIC values. However, the effect was abolished after only one passage in fresh medium, indicating a 
reversible tolerance. Sallum & Chen (2008) reported the same rapid reverting of the MIC value to 
the antimicrobial peptide cecropin B for V. anguillarum and Vibrio vulnificus. 
The fact that it was not possible to select TDA resistant mutants could indicate that more than one 
mutation or genetic change in the bacterial genome is needed in order to gain resistance to TDA. 
This is also the case for antimicrobial peptides and biocides (Russell, 2003; Peschel et al., 2006). 
However, a large number of mutations may be detrimental to the bacterial cell, and hence, not likely 
to co-occur. The transient, slightly increased tolerance to TDA is most likely caused by a 
phenotypic switch caused by e.g. altered gene expression. 
5.2.5 Self­protection of tropodithietic acid producing strains 
Many bacteria produce antibiotics that potentially could be toxic to themselves (Martín et al., 
2005). Typically, organisms producing antibiotics have evolved resistance mechanisms for 
protection against their own drug. The mechanisms for self-protection include (Cundliffe, 1991): 
 Development of membrane permeability barriers coupled with efficient efflux mechanisms 
for removal of drug molecules from the cells 
 Inactivation or sequestration of intracellular drug molecules and any biologically active 
precursors thereof 
 Modification or replacement of the target site(s) at which specific drugs normally act 
Genes involved in biosynthesis of an antibiotic is often organized in a clusters, and close to these 
clusters genes encoding resistance to the antibiotic or genes encoding efflux pumps or other 
transporter systems can be found (Martín et al., 2005). In some Streptomyces species, ABC 
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transporters are involved in pumping the antibiotic out of the producer strain (Rodríguez et al., 
1993; Linton et al., 1994). there are many ABC transporter genes in the proximity of genes 
encoding the biosynthesis of TDA in Phaeobacter and Ruegeria strains (tdaABCDE and tdaF). An 
ABC transporter system is located just before the tdaA gene in Phaeobacter gallaeciensis strain 
SK2.10 and BS107, and a transcriptional regulator, LysR-like, is located upstream the transporter 
genes. In addition, two ABC transporter genes are localized between tdaE and tdaF, but no 
transporter genes are found after tdaF. This could indicate that these ABC transporters systems are 
involved in protection of Phaeobacter strains against TDA. 
In this work, it was found that the TDA producer strain Phaeobacter strain 27-4 was not protected 
against TDA (Porsby et al., 2010). This could be due to the conditions that were used for 
determining the MIC value, as it was determined after incubation for two days. TDA is produced in 
the late exponential growth phase, and perhaps a self-protection-mechanism such as ABC 
transporters is only expressed when TDA is beeing produced. Geng & Belas (Geng et al., 2010) 
suggested that TDA functions as an autoinducer of its own biosynthesis, however, it can also be 
speculated if TDA induce expression of the ABC transporter systems through activation of the LysR 
gene. Thereby these transporters are only expressed when TDA is being produced. 
TDA could also be inactivated in the producer cell as a part of the biosynthesis e.g. by binding 
another compound to the TDA molecule. This TDA containing molecule, which are not lethal to the 
producer strain, are then exported out of the cell by the ABC transporters. Finally, TDA and the in-
activator molecule are separated and TDA now have antibacterial activity. Enough is not known 
about the biosynthesis of TDA to confirm or reject this theory. 
5.3 Conclusions from chapter 5 
Antimicrobials such as antibiotics, antimicrobial peptides and biocides have different mechanisms-
of-actions. TDA, which is bactericidal against both Gram-negative and Gram-positive bacteria, 
probably targets the bacterial cell envelope, likely the peptidoglycan. This is a well-known target 
for some antibiotics (e.g. β-lactams and glycopeptides), but also antimicrobial peptides attack the 
cell wall. Strains with resistance or tolerance to TDA were very hard to select, and this could 
indicate that TDA have multiple target sites in a bacteria which it is the case for biocides. Also, the 
slight increase in tolerance was not stable. Therefore, it is hypothesized that the transient increase in 
TDA tolerance is due to a phenotypic switch caused by e.g. altered gene expression. The fact that 
resistance and enhanced tolerance is difficult to obtain, is promising from an application point of 
view. It is not likely that the use of TDA producing bacteria as fish probiotic will lead to TDA 
resistance among fish pathogenic bacteria, thereby, the probiont will not lose its disease preventing 
effect due to decreased sensitivity among the fish pathogenic bacteria. 
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6 Concluding remarks and future perspectives 
The aquaculture sector is expanding rapidly to the benefit of the growing world population.  
However, bacterial diseases are important constraints to this growth. Today some of these diseases 
are controlled with antibiotics, however, due to fear of development of resistant bacteria and spread 
of this resistance among bacteria in the food chain, alternatives to antibiotics are needed. Probiotic 
organisms, which are “live organisms which when administered in adequate amounts confer a 
health benefit on the host” (FAO/WHO, 2001), can be the solution in some cases e.g. in marine 
larvae cultures. Such probiotic organisms could be bacteria belonging to the Roseobacter clade. 
Roseobacter clade members are common in marine environments as both non-culturable clones and 
easily culturable isolates. In natural settings, they are often associated with surfaces or particles 
indicative of a preference for an attached lifestyle. The Roseobacter clade species Phaeobacter 
gallaeciensis, Phaeobacter inhibens and Ruegeria mobilis colonize turbot rearing facilities in both 
Denmark (this thesis) and Spain despite the very different water sources (the Galician Atlantic 
Ocean opposed to the Danish fjord Limfjorden). Members of the clade can also be found in 
aquaculture settings of e.g. haddock, cod and different molluscs such as scallops, oysters and clams. 
The success of Roseobacter clade bacteria in natural environments and in aquaculture can 
potentially be explained by their ability to produce antagonistic compounds, which is assumed to 
give them an advantage over other organisms. The species Ph. gallaeciensis, Ph. inhibens and R. 
mobilis inhibit or kill a variety of fish pathogenic and marine bacteria, probably due to the 
antagonistic effect of the secondary metabolite tropodithietic acid (TDA).  However, at the same 
time they are not lethal to egg yolk sac larvae. The fact that these bacteria are naturally occurring in 
aquaculture and seem to be superior to other bacteria makes them promising probiotic candidates. 
One way to reveal if TDA is causing a probiotic effect would be to conduct in vivo experiments 
where e.g. larvae are infected with a pathogen and treated with a TDA producing strain (wildtype) 
or a knockout mutant deficient of TDA production. 
Production of TDA is influenced by environmental parameters such as temperature and presence of 
marine salts, but also by the physical environment. Work in this thesis show that Ruegeria strains 
only produce TDA when grown at stagnant conditions, whereas Phaeobacter strains produce the 
compound both at shaking and stagnant conditions. A brown pigment, the ability to inhibit Vibrio 
anguillarum strain 90-11-287 and growth in rosette-like structures co-occur with TDA production. 
To the best of my knowledge, the only exception is strain 27-4 which based on 16S rRNA and gyrB 
phylogeny is identified as a Phaeobacter, but phenotypically it behaves like the Ruegeria strains. 
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The ability to grow in rosettes and the production of TDA always seem to co-occur in both 
Phaeobacter and Ruegeria species. Furthermore, the brown pigment is produced in the top layer of 
a stagnant culture which is also where the rosette-formation is observed. Therefore, it would be 
interesting to investigate if TDA production only takes place in cells that grow in rosettes and not in 
planktonic cells, and if the phenotype is mediated by the physical conditions at the air-liquid 
interphase. 
The biosynthesis of TDA is not fully understood, and only some of the genes involved have been 
identified. It is still unknown e.g. how the two sulfur molecules are added to TDA. The genes 
tdaABCDEF are essential to biosynthesis of TDA and they have been identified in all genome 
sequenced strains which produce TDA. In Ruegeria strain TM1040 they are located on a plasmid, 
whereas in Phaeobacter strain BS107 and SK2.10 they are found on the chromosome. From an 
applied point of view, it is an advantage to use a strain with the “producer genes” located on the 
chromosome, as plasmids can be lost spontaneously leading to a probably non-effective probiont. 
In the present thesis, it was shown that TDA is bactericidal to both Gram-negative and Gram-
positive bacteria, however, the Gram-negative bacteria are generally less sensitive to the compound. 
TDA is also bactericidal to non-growing cells. It is suggested that TDA does not have to enter the 
bacterial cell to reach its target, and therefore, the cell envelope might contain the target site(s) for 
TDA. This is supported by the biosensor results that also pointed to the cell envelope as target and 
perhaps the peptidoglycan structure. 
It was not possible in this PhD study to obtain TDA resistant mutants which can indicate that TDA 
has multiple target sites in or on the bacterial cell, hence, resistance requires a multitude of 
mutations that are unlikely to co-occur. Only low levels of tolerance could be induced by multiple 
exposures to subinhibitory concentrations of TDA. However, the decreased sensitivity to TDA was 
abolished after one passage without the compound. This transient tolerance might be due to a 
phenotypic switch which is rapidly reversed. This switch phenomenon may be caused by e.g. 
altered gene expression and is not due to changes in the DNA. 
It is hypothesized that TDA is also produced in natural setting (e.g. aquaculture) but it is unknown 
at which concentrations. It is plausible that fish pathogenic bacteria in a fish tank will experience 
subinhibitory concentrations of TDA upon use of a TDA producing bacteria as probiont. 
Subinhibitory of antibiotics is known to cause altered virulence gene expression in other bacteria 
(Weir et al., 2008; Nanduri et al., 2009). From an application point of view, it would be important 
to know if subinhibitory concentrations of TDA influence the virulence of fish pathogenic bacteria. 
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TDA producing bacteria have been added to fish larvae and also co-cultured with algae and do not 
have adverse effects on neither of the eukaryotes (D’Alvise, unpublished data). However, any side 
effects of long term exposure of eukaryotes to TDA need to be investigated. 
Assuming that TDA is not toxic, the broad spectrum of activity of TDA also evokes interest in the 
compound as an antibiotic with broader use, e.g. in humans. TDA is unstable at 30ºC and above 
(Bruhn et al., 2005), and this could be either advantageous ensuring a rapid turnover or a drawback 
hampering efficient use. 
Members of the Roseobacter clade are abundant in several natural marine environments and they 
seem to prefer a surface attached lifestyle. Some species within the Roseobacter clade grow in 
rosette-like structures, and this phenotype co-occurs with increased attachment ability. It can be 
speculated if this rosette-state triggers TDA production. The cells are in a state where they are ready 
to attach to a surface, and they need TDA as “a weapon” to remove other attached bacteria to get a 
spot on the surface. 
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Members of the Roseobacter clade colonize a Spanish turbot larval unit, and one isolate (Phaeobacter
strain 27-4) is capable of disease suppression in in vivo challenge trials. Here, we demonstrate that
roseobacters with antagonistic activity against Vibrio anguillarum also colonize a Danish turbot larval
farm that relies on a very different water source (the Danish fiord Limfjorden as opposed to the Galician
Atlantic Ocean). Phylogenetic analyses based on 16S rRNA and gyrase B gene sequences revealed that
different species colonized different niches in the larval unit. Phaeobacter inhibens- and Phaeobacter
gallaeciensis-like strains were primarily found in the production sites, whereas strains identified as
Ruegeria mobilis or Ruegeria pelagia were found only in the algal cultures. Phaeobacter spp. were more
inhibitory against the general microbiota from the Danish turbot larval unit than were the Ruegeria spp.
Phaeobacter spp. produced tropodithietic acid (TDA) and brown pigment and antagonized V. anguillarum
when grown under shaking (200 rpm) and stagnant (0 rpm) conditions, whereas Ruegeria spp. behaved
similarly to Phaeobacter strain 27-4 and expressed these three phenotypes only during stagnant growth.
Both genera attached to an inert surface and grew in multicellular rosettes after stagnant growth, whereas
shaking conditions led to single cells with low attachment capacity. Bacteria from the Roseobacter clade
appear to be universal colonizers of marine larval rearing units, and since the Danish Phaeobacter spp.
displayed antibacterial activity under a broader range of growth conditions than did Phaeobacter strain
27-4, these organisms may hold greater promise as fish probiotic organisms.
Bacteria from the Roseobacter clade are widely distributed in
marine environments (37, 51), and this group includes 38 dif-
ferent genera (7). The organisms constitute 20 to 30% of
prokaryotes in 16S rRNA gene libraries from surface water
(11). Even though the clade is detected often, little is known
about the species distribution and biogeography in the oceans
(7) and in more closed environments like fish farms using
oceanic water.
Some members of the Roseobacter clade produce secondary
metabolites (23, 31), and the production of, e.g., antimicrobial
compounds may contribute to their dominance in several
niches. Also, the secondary metabolite production has caused
interest in the Roseobacter clade from a biotechnological per-
spective. For instance, Phaeobacter gallaeciensis (formerly Ro-
seobacter gallaeciensis) (35) and Phaeobacter inhibens are an-
tagonistic against bacteria such as Vibrio anguillarum, Vibrio
splendidus, Vibrio cholerae, Bacillus subtilis, Halomonas spp.,
and Pseudoalteromonas sp. due to production of tropodithietic
acid (TDA) (6, 8, 9, 28). The antagonism against Vibrio species
and the association of some roseobacters with algae (1, 11, 22)
have spurred an interest in P. inhibens as a possible fish pro-
biotic organism, as algae are typically used as live feed in
marine larval rearing. Probiotics have been defined by FAO/
WHO (17) as “live microorganisms which when administered
in adequate amounts, confer a health benefit on the host.”
Indeed it has been demonstrated that the survival of scallop,
bream, and turbot larvae can be increased by adding cell ex-
tracts of roseobacters to the tank water or feeding the larvae
with rotifers loaded with the probiont (34, 39, 44).
The Roseobacter clade is one of the dominant groups of
colonizers on surfaces in marine environments (13), and in a
Spanish turbot larval unit roseobacters were found more often
on surfaces (e.g., tank walls) than in the water and a number of
specific subtypes appeared as stable colonizers of the rearing
unit (29). Specifically, for the Phaeobacter strain 27-4, which
was isolated from a Spanish turbot farm, it was demonstrated
that production of the anti-Vibrio substance TDA occurred
only under growth conditions that also facilitated biofilm for-
mation at the air-liquid interface and on inert surfaces (8, 9).
With the rapidly growing aquaculture industry now supply-
ing more than 40% of the fish used for human consumption
(16), there is an intense interest in disease control measures
that do not rely on classical antibiotics. The roseobacters, as
mentioned, appear to be one such option as fish probiotics.
However, it is not known if their colonization of the Spanish
turbot larval unit is a unique finding or if the clade in general
due to its association with algae and its dominance in the
* Corresponding author. Mailing address: National Institute of
Aquatic Resources, Technical University of Denmark, Søltofts Plads,
Bldg. 221, DK-2800 Kgs. Lyngby, Denmark. Phone: 45 45 25 49 28.
Fax: 45 45 88 47 74. E-mail: chh@aqua.dtu.dk.
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marine environment will be a common component of the mi-
crobiota in marine fish-rearing units and, hence, a more uni-
versal fish probiotic candidate.
The purpose of the present study was to determine if isolates
belonging to the Roseobacter clade also were selected in a
turbot larval farm using a water source (water from a Danish
fiord) very different from the Atlantic marine waters used in
Galician turbot-growing facilities. In the model organism,
Phaeobacter strain 27-4, anti-Vibrio activity is tightly coupled
with specific (stagnant) growth conditions, and the purpose of
the present study was also to determine if this is a general trait
in Roseobacter clade strains that produce TDA. From an ap-
plied fish-farming perspective, it would be advantageous to
select probiotic strains where anti-Vibrio activity occurred un-
der a broad range of growth conditions.
MATERIALS AND METHODS
Bacterial strains. The target strain used for testing antimicrobial activity of
bacteria from the turbot-growing unit was V. anguillarum 90-11-287 (serotype
O1) isolated from rainbow trout (46). Roseobacter clade strains 27-4, 8-1, 234-2,
234-9, 234-10, 256-7, 267-1, 270-3, and 632-1 were isolated from two Spanish
turbot-rearing units due to their antimicrobial properties (28). Silicibacter sp.
strain TM1040 originates from dinoflagellate cultures of Pfiesteria piscicida (36).
All strains were stored at 80°C in a freeze medium (30.0 g tryptone soy broth
[Oxoid CM129B; Oxoid, Hampshire, England], 5.0 g glucose, 20.0 g skim milk
powder, 40.0 g glycerol, 1000 ml H2O) (21). Strains were cultured on marine agar
2216 (MA; Difco, BD, Sparks, MD) or in marine broth 2216 (MB; Difco) for 2
to 3 days at 25°C.
Sampling and isolation of antimicrobial strains. Samples were taken for
microbiological analysis from a Danish turbot larval farm in October 2006. The
turbot unit used water from Limfjorden, which is a shallow fiord transecting the
Danish Jutland peninsula, and the salinity is around 2.5%. Samples were col-
lected from walls and water from fish tanks; tanks with rotifers, nauplii, and
zooplankton; and bags with algal cultures. Sterile gloves, swabs, and plastic
beakers were used for sampling. All samples were 10-fold diluted in sterile
seawater and spread onto MA. Liquid samples were diluted directly, whereas
swab samples were mixed thoroughly with 1 ml autoclaved seawater (constituting
a 100 dilution.). MA plates were incubated for 6 days at 20°C. To isolate colonies
with antimicrobial activity, MA plates were replica plated onto seawater agar
(1,000 ml seawater, 3.33 g Casamino Acids [Difco 223050], 20 ml 20% glucose,
and 10 g agar) plates containing 5  105 to 1  106 CFU of V. anguillarum
90-11-287/ml agar. The agar was held at 44°C and mixed with V. anguillarum
90-11-287 previously grown in 10 ml MB for 2 days at 25°C. Colonies causing
clearing zones after incubation of the seawater agar plates for 24 h at 25°C were
isolated from the original MA plate and pure cultured. All strains were tested in
a spot inoculation test and a well diffusion assay using colony mass and sterile-
filtered supernatants, respectively, to verify the antimicrobial activity. In both
assays, the agar was seeded with V. anguillarum 90-11-287 as described above,
and Phaeobacter strain 27-4 was used as a positive control. Colonies of strains
grown on MA at 25°C for 3 days were inoculated in one spot (approximately 0.5
cm) on seawater agar or Instant Ocean agar (1,000 ml H2O, 30.0 g Instant Ocean
[Aquarium Systems Inc., Sarrebourg, France], 3.33 g Casamino Acids, 20 ml 20%
glucose, and 10 g agar). The clearing zone around the spot was read after 24 and
48 h at 25°C. For the well diffusion assay, 70 l sterile-filtered (pore size, 0.22
m; Millipore, Bedford, MA) supernatants of each isolate grown in 10 ml MB in
25-ml bottles for 3 days at 25°C under stagnant or shaking (200 rpm) conditions
were added to wells (diameter, 6 mm) in solidified seawater agar. Diameters of
clearing zones were measured after 24 h at 25°C.
Sampling and isolation of strains representing the general microbiota. To
determine if the Roseobacter clade bacteria would have a pronounced effect on
the general microbiota of the turbot larval farm, we investigated the ability of the
Roseobacter clade strains to inhibit representative strains of the microbiota. Plate
counts on six samples collected from the Danish turbot farm in January and
February 2008 from three tanks (water and surfaces) were performed as de-
scribed above. Colonies were isolated randomly and pure cultured. Spot assays
were performed with 17 isolates embedded in Instant Ocean agar, and the
Roseobacter clade strains were spotted on top of it as described above.
Phaeobacter strain 27-4 was also tested against the 17 isolates. The 17 isolates
were identified by biochemical tests and BLASTN (2) search on the National
Center for Biotechnology Information (NCBI) database (4) (98% identity)
using 16S rRNA sequences (for biochemical tests and sequencing procedures,
see below).
Identification of bacteria. Biochemical tests were used to identify the isolates
which retained antimicrobial activity as determined by spot assay or that were
isolated as representatives of the turbot-rearing microbiota. Gram stain (Bacti-
dent aminopeptidase; Merck, Darmstadt, Germany), catalase (3% H2O2), and
oxidase (BBL Oxidase Dryslide; BD) reactions were tested on cultures grown for
1 day on MA at 25°C. Shape, motility, and ability to form rosettes were examined
by phase-contrast microscopy of cultures grown in MB for 3 days at 25°C under
stagnant conditions. The ability to ferment or oxidize glucose was tested in OF
basal medium (Merck) (30) supplemented with 2% Instant Ocean. Fermentative
strains were grown for 1 day at 25°C in 5 ml MB and streaked on plates selective
for vibrios (TCBS cholera medium [Oxoid CM333]), and the cultures were also
tested for sensitivity to vibriostaticum (2,4-diamino-6,7-di-isopropylteridine;
0/129 DD0014, 10 g, and DD0015, 150 g; Oxoid) on MA. All plates were
incubated at 25°C for 24 h.
Bioinformatics on Roseobacter clade strains. The 16S rRNA genes of pre-
sumed Roseobacter clade strains (gram-negative, nonfermentative/nonoxidative,
motile rods with positive catalase and oxidase reactions and the ability to form
rosettes and brownish pigment) were sequenced not only to identify the isolates
but also to determine similarities of the strains isolated from the Danish and
Spanish turbot-rearing units. The gyrase B (gyrB) genes were sequenced to
determine if the very homogenous clusters found by comparing 16S rRNA genes
were also reflected in this housekeeping gene.
DNA was purified from cultures grown for 3 days at 25°C in 5 ml MB using the
Dynal Dynabeads DNA Direct System (Dynal Biotech ASA, Oslo, Norway). Two
microliters DNA was mixed with 13 l 2 Brilliant IIQPCR Master Mix (Strat-
agene, La Jolla, CA), 8 l sterile MilliQ water, and 1 l 12.5 M of each primer.
The primers were synthesized by DNA Technology A/S (Aarhus, Denmark), and
we used 27F (5 AGAGTTTGATCMTGGCTCAG 3) and 1492R (5 TACGG
YTACCTTGTTACGACTT 3) for 16S rRNA genes and UP-1 (5 GAAGTCA
TCATGACCGTTCTGCAYGCNGGNGGNAARTTYGA 3) and UP-2 (5
AGCAGGGTACGGATGTGCGAGCCRTCNACRTCNGCRTCNGTCAT 3)
for gyrB genes (52). The PCRs for 16S rRNA genes were run (9800 Fast Thermal
Cycler; Applied Biosystems, Foster City, CA) for 10 min at 95°C before 35 cycles
of 95°C for 30 s, 51°C for 1 min, and 72°C for 1.5 min and, after the last cycle, 7
min at 72°C. For the gyrB genes, the reactions were run for 10 min at 95°C
followed by 40 cycles of 1 min at 95°C, 1 min at 60°C, and 2 min at 72°C. The
program ended with 7 min at 72°C. All PCR products were analyzed by 1%
agarose gel electrophoresis, bands were cut out, and DNA was purified (GFX
PCR DNA and gel band purification kit; GE Healthcare, Buckinghamshire,
Great Britain). Sequencing was done by DNA Technology A/S using the primer
set 518F (sequence, 5 CCAGCAGCCGCGGTAATACG 3) and 800R (se-
quence, 5 TACCAGGGTATCTAATCC 3) for 16S rRNA genes and UP1S (5
GAAGTCATCATGACCGTTCTGCA 3) and UP2Sr (5 AGCAGGGTACGG
ATGTGCGAGCC 3) for gyrB genes (52).
Sequences were assembled using Vector NTI (Invitrogen, Carlsbad, CA).
BLASTN searches using 16S rRNA sequences were performed on the NCBI
database to find sequences with 98% identity. Relevant type strains for species
identified were found online in the List of Prokaryotic Names with Standing in
Nomenclature (15) and included in the analysis. Multiple alignments were done
using the program ClustalX (48), and the alignments were edited in BioEdit (25).
Distance matrix JC was calculated using ClustalX and neighbor joining (45), and
bootstrap (number of trials, 100) (18) trees were drawn using the program
MEGA4 (47). Type strains Rhodobacter capsulatus ATCC 11166 plus
Rhodobacter sphaeroides ATCC 17023 and Roseobacter denitrificans Och114 plus
Roseobacter litoralis Och149 served as outgroups in the 16S rRNA and gyrB trees,
respectively.
Subtyping of Roseobacter clade strains by RAPD. Roseobacter clade isolates
were random amplified polymorphic DNA (RAPD) typed as described earlier
(50) to determine subspecies homology. In brief, 2 l purified DNA plus one
Ready-To-Go RAPD Analysis Bead (Amersham Pharmacia Biotech Inc., Pisca-
taway, NJ) was dissolved in 23 l of one of the following 1 M primers (DNA
Technology A/S): UBC 104 (sequence 5 GGGCAATGAT 3) and UBC 106
(sequence 5 CGTCTGCCCG 3) (29). The PCRs were run at 95°C for 2 min
followed by 10 cycles of 1 min at 94°C, annealing at 45°C for 1 min, and extension
at 72°C for 2 min. The annealing temperature was decreased by 1°C per cycle.
Then 30 cycles followed with denaturing at 94°C for 1 min, annealing at 35°C
for 1 min, and extension at 72°C for 2 min. The program was completed with
10 min of final extension at 72°C. The bands were visualized after electro-
phoresis in 2% agarose gels by staining with ethidium bromide. Phaeobacter
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strains (27-4, 8-1, and 632-1) and a 100-bp ladder (Amersham) standard were
included in all gels.
Influence of growth conditions on attachment, pigment formation, and anti-
bacterial activity of Roseobacter clade strains. All Roseobacter clade strains were
grown in 5 ml MB for 3 days at 25°C under stagnant conditions, and 200 l was
reinoculated in 20 ml MB in 250-ml bottles and grown for 3 days at 25°C under
stagnant or shaking (200 rpm) conditions. Sterile-filtered supernatants were used
for testing antimicrobial activity in a well diffusion assay in Instant Ocean agar as
described above and for measuring pigment by spectroscopy (Novaspec II; Phar-
macia Biotech, Cambridge, England) at 398 nm (9). Cell numbers were deter-
mined on cultures by 10-fold dilutions in sterile 0.85% saline and plated on MA,
and plates were incubated at 25°C for 3 days. A subset of seven Roseobacter clade
strains from the Danish turbot larval farm, four from the Spanish turbot larval
farm, the strain from a dinoflagellate culture, and the V. anguillarum strain not
able to form rosettes were examined for their ability to attach to surfaces as
described by Bruhn et al. (8). Briefly, glass coverslips (Knittel Gla¨sser, Braun-
schweig, Germany) were dipped for 5 s in cultures grown in 20 ml MB in 250-ml
bottles for 3 days at 25°C under stagnant or shaking (200 rpm) conditions as
described above. Loosely attached cells were removed by placing the coverslip on
absorbent paper, after which the remaining cells were fixed at 60°C for 30 min.
Attached cells were stained for 15 min in 0.1% crystal violet, and unbound dye
was washed off using phosphate-buffered saline (BR0014G; Oxoid). Dye bound
to attached cells was dissolved in 2 ml 33% acetic acid, and the optical density at
590 nm (OD590) was measured. The attachment was done in duplicate. The
crystal violet OD resulting from dipping glass coverslips in pure MB were sub-
tracted from all measurements. Phase-contrast microscopy was performed on
cells from the air-medium interface of the cultures. Pigment was measured as
described earlier (9). The antibacterial compound TDA was measured in sterile-
filtered supernatant as described below.
HPLC-tandem mass spectrometry analysis of TDA. Extracts of 5 l were
analyzed on an Agilent (Torrance, CA) 1100 high-pressure liquid chromatogra-
phy (HPLC) system controlled by MassLynx V4.1. Samples were separated on a
Gemini C6-phenyl 3-m, 2-mm-inside-diameter 50-mm column (Phenomenex,
Torrance, CA), using a flow rate of 0.300 ml/min at 25°C. A linear water-
acetonitrile (ACN) gradient was used, starting at 10% ACN, going to 45% ACN
in 8 min and then 100% ACN in 0.5 min, holding this for 2 min before reverting
to 10% ACN in 1 min, and maintaining this for 8 min. Both solvents contained
120 mM formic acid. The HPLC was a coupled Quattro Ultima triple mass
spectrometer (Waters-Micromass, Manchester, United Kingdom) with a Z-spray
electrospray ionization source using a flow rate of 700 liters/h nitrogen at 350°C;
hexapole 1 was held at 30 V, and the cone was held at 25 V. Nitrogen was used
as collision gas, and the mass spectrometer operated in positive multiple-reaction
monitoring mode (dwell time, 100 ms), monitoring m/z 213 to 151 (25-V collision
energy) and m/z 213 to 167 (20-V collision energy) as quantifier and qualifier
ions, respectively.
Nucleotide sequence accession numbers. The 16S rRNA and gyrB gene se-
quences have been deposited in GenBank under the accession numbers
FJ014969 to FJ01503 and FJ014947 to FJ014968, respectively.
RESULTS
Sampling, isolation, and identification of antimicrobial
strains. Forty-three samples from the Danish turbot larval
farm (Table 1) all had aerobic plate counts of 105 to 106
CFU/ml on MA. Thirty-one samples contained colonies that in
the replica assay indicated inhibition of V. anguillarum. We
isolated cells from 117 of these colonies, and upon retesting,
the inhibitory activity was retained for 100 isolates. Fifty-four
of the 100 isolates also inhibited V. anguillarum 90-11-287
when we used sterile-filtered supernatant from stagnant cul-
tures in the well diffusion assay. These isolates originated from
water (23 isolates), tank surfaces (22 isolates), and algal cul-
tures (nine isolates). Instant Ocean agar was used for all sub-
sequent experiments, as this is easier to standardize than an
agar based on natural seawater, and gave very similar inhibi-
tory profiles. Fifty-one of the 54 isolates were gram-negative,
nonfermentative/nonoxidative, motile rods with positive cata-
lase and oxidase reactions and rosette formation and therefore
were likely to belong to the Roseobacter clade. It was not
possible, based on the biochemical tests used, to identify the
last three isolates. The 46 isolates that were antagonistic only
in the spot assay and not in the well diffusion assay were
primarily identified as Vibrio spp. (38 out of 46), being fermen-
tative, gram-negative rods able to grow on TCBS agar and in
the presence of vibriostaticum.
BLASTN searches supported the Roseobacter clade affilia-
tion of the 51 isolates, as all 16S rRNA gene sequences showed
98% similarity to species such as Roseobacter spp., P. inhi-
bens, P. gallaeciensis, and Phaeobacter daeponensis, whereas
isolates from algal cultures were 98% similar to Ruegeria
mobilis, Ruegeria pelagia, and Silicibacter spp. (Table 2).
RAPD subtyping of Roseobacter clade strains. RAPD typing
divided the 51 Roseobacter clade strains into 14 different sub-
types when two primers were used (data not shown). None of
these types were similar to three major RAPD types that had
been found in the Spanish turbot-rearing farms (29). Three
major subgroups found in the Danish turbot-rearing unit were
designated AA, BB, and CC and harbored 23, 4, and 9 strains,
respectively. All the 23 subtype AA strains originated from
TABLE 1. Numbers of samples taken at a Danish turbot larval
farm and numbers of isolates with antagonistic activity
against Vibrio anguillarum strain 90-11-287
in seawater agar
Sample site
No. of samples No. of antagonistic isolates
Total
No. with
antagonistic
bacteria
determined
by replica
plating
Total
Determined
by spot
assay
Determined
by well
diffusion
assay
Inside production
Fish tanks
Water 4 3 12 11 5
Surface 9 3 7 7 6
Water cleaning system
Water 3 3 13 12 5
Surface 2 2 10 9 9
Tank with copepod
cultures
Suspension 4 3 9 2 0
Surface 4 4 11 8 0
Bag with algal culture,
suspension
4 3 11 11 9
Subtotal 30 21 (70%) 73 60 (82%) 34 (47%)
Outside production
Tanks with larvae
Water 2 2 11 11 6
Surface 2 1 1 1 1
Tanks with
zooplankton
Water 2 2 11 9 5
Surface 2 1 7 6 6
Water cleaning system,
surface
1 1 2 2 0
Tank with water from
the inlet
Water 1 1 5 5 0
Surface 1 1 3 2 0
Tank with nauplii
Water 1 1 4 4 2
Surface 1 0 0 0 0
Subtotal 13 31 (76%) 44 40 (90%) 20 (45%)
Grand total 43 31 (76%) 117 100 (85%) 54 (46%)
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parts of the production site that were indoors. Only two indoor
isolates belonged to other subtypes (BB and DD). The RAPD
type CC encompassed nine strains, and all were isolated
from the algal cultures. All of these nine strains were sub-
sequently identified by 16S rRNA gene sequencing as Rue-
geria spp. Subtype BB harbored four strains isolated at dif-
ferent sites. The remaining 17 isolates were isolated from
the outdoor sites of the production unit and made up a total
of 11 RAPD types.
16S rRNA and gyrB gene comparison of Roseobacter clade
strains. Three major clusters appeared when comparing 989
bases of the 16S rRNA gene from 48 Danish and nine Spanish
Roseobacter clade isolates (Fig. 1a). Three Danish isolates
could not be amplified. One cluster was identical to type strains
R. mobilis MBIC01146 and R. pelagia HTCC2662 and con-
tained nine isolates representing two samples from Danish
algal cultures and one Spanish isolate. Twenty-one Danish
isolates from seven indoor samples (all RAPD type AA) and
eight isolates from the Spanish turbot farm clustered together
with the type strain P. gallaeciensis BS107. The last cluster
consisted of the type strain P. inhibens T5 and Danish isolates
of different RAPD types. Fifteen isolates were from five out-
door samples, and two isolates were taken from two different
indoor samples. The gyrB gene (998 bases) was sequenced for
19 Danish and three Spanish strains representing the different
clusters obtained in the 16S rRNA tree. It resulted in the same
three major clusters when this housekeeping gene was used as
did the 16S rRNA gene sequences; however, a greater sepa-
ration between the Danish and the Spanish strains was
achieved using the gyrB sequences (Fig. 1b). Furthermore, the
Spanish isolate 8-1 was affiliated with the P. gallaeciensis BS107
cluster in the 16S rRNA tree whereas in the gyrB tree it
grouped with the strains from the P. inhibens T5 cluster.
The gyrB sequences of some isolates revealed putative stop
codons in five isolates (Phaeobacter strains M3-1.2, M4-3.1,
M6-4.1, M9-4.2, and M9-4.3) or frameshift mutations in 12
isolates (Phaeobacter strains 8-1, 27-4, M2-3.1, M2-4.2, M3-1.3,
M4-3.1, M6-4.1, M9-4.1, M9-4.2, and M9-4.3 and Ruegeria
strains M41-3.1 and M43-1); however, the reason for this or the
functional implications have not been further pursued.
Inhibition of the general microbiota by Roseobacter clade
strains. Seventeen isolates randomly collected from water and
TABLE 2. Identification of antagonistic bacterial strains isolated from a Danish turbot larval farm
Sampling site
No. of isolates antagonistic in:
Both spot and well diffusion assaysa Spot but not well diffusion assayb
Phaeobacter
spp.
Ruegeria
spp. Others
Roseobacter-
like
Vibrio
spp. Others
Indoor production
Fish tanks
Water 5 0 0 0 6 0
Surface 6 0 0 0 1 0
Water cleaning system
Water 5 0 0 0 7 0
Surface 9 0 0 0 0 0
Tank with copepod cultures
Suspension 0 0 0 0 1 1
Surface 0 0 0 0 4 4
Bag with algal culture, suspension 0 9 0 1 0 1
Subtotal 25 9 0 1 19 6
Outdoor production
Tanks with larvae
Water 6 0 0 0 5 0
Surface 1 0 0 0 2 0
Tanks with zooplankton
Water 4 0 1 0 4 0
Surface 6 0 0 0 0 0
Water cleaning system, surface 0 0 0 0 2 0
Tank with water from the inlet
Water 0 0 0 0 5 0
Surface 0 0 0 0 0 0
Tank with nauplii
Water 0 0 2 0 1 1
Surface 0 0 0 0 0 0
Subtotal 17 0 3 0 19 1
Grand total 42 9 3 1 38 7
a Identified by BLASTN search with 16S rRNA gene sequences on the NCBI database.
b Identified by biochemical tests (Gram stain, catalase and oxidase tests, ability to metabolize glucose, reaction on TCBS plates, and sensitivity/resistance to the
vibriostatic agent 0129) and microscopy (motility, shape, and ability to form rosettes).
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surface samples from the Danish turbot larval farm were in-
hibited by the 51 Roseobacter clade strains, although some of
the strains were inhibited to a lesser degree than was V. an-
guillarum 90-11-287, as indicated by the size of the inhibition
zone (Table 3). The inhibition zones surrounding the 42
Phaeobacter sp. strains in the spot assay were larger than the
zones produced by the nine Ruegeria sp. strains. This pattern
was especially pronounced for target strains isolated from wa-
ter samples. The 17 isolates were identified as eight different
genera or species, and one isolate was impossible to identify
based on the methods used. The Phaeobacter spp. strongly
inhibited all but one isolate (Rhodococcus sp.), whereas the
FIG. 1. Phylogenetic trees constructed using the 16S rRNA gene (a) and gyrase B (gyrB) gene (b) sequences. Numbers at the nodes are
bootstrap values from 100 replicates. Type strains Rhodobacter capsulatus ATCC 11166 and Rhodobacter sphaeroides ATCC 17023 served as
outgroups in the 16S rRNA tree, and Roseobacter denitrificans Och114 and Roseobacter litoralis Och149 served as outgroups in the gyrB gene trees
(not shown). and f, Danish and Spanish turbot-rearing farm strains, respectively. T, type strains.
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Ruegeria spp. inhibited all but six isolates (Halomonas sp./
Cobetia marina, Pseudomonas sp., Pseudoalteromonas sp., and
Rhodococcus sp.). There was no pattern in the sensitivity of the
target strains to Roseobacter clade strains depending on genus
or species of the target organism.
Influence of growth conditions on attachment, pigment for-
mation, and antibacterial activity of Roseobacter clade strains.
All the 51 Danish and nine Spanish Roseobacter clade strains
produced brown pigment (as determined by OD398) when
grown under stagnant conditions in MB. However, 42 Danish
and seven Spanish isolates also produced pigment when grown
under aerated (shaking) conditions, although the amount of
pigment was less than that in stagnant cultures (data not
shown), and all these strains were identified as Phaeobacter
spp. The brown pigment correlated with the antibacterial ac-
tivity of the supernatant in the well diffusion assay, as inhibition
was observed only when pigment was produced. The remaining
nine Danish and two Spanish isolates expressed these pheno-
types only during stagnant growth. Of these, all Danish strains
and one Spanish strain were identified as Ruegeria spp., and the
last Spanish strain behaving like the Ruegeria spp. was
Phaeobacter strain 27-4. All stagnant and shaken cultures grew
to approximately 5  108 CFU/ml and 1  109 CFU/ml, re-
spectively. It was examined for a subset of samples (eight
Phaeobacter sp. strains, three Ruegeria sp. strains, Silicibacter
strain TM1040, and V. anguillarum 90-11-287) if rosette for-
mation and attachment ability co-occurred with pigment pro-
duction and antibacterial activity as seen for Phaeobacter strain
27-4 (8, 9). All Roseobacter clade isolates attached better to the
glass surface as determined by crystal violet staining when
grown under stagnant conditions (Fig. 2), and more cells ap-
peared in a rosette morphology under stagnant conditions than
under shaking conditions (Fig. 3) (data are shown only for the
Danish Phaeobacter strain M23-3.1, the Spanish Phaeobacter
strain 27-4, and the Danish Ruegeria strain M43-2.3 but are
typical for the other Roseobacter clade strains). This was also
the case for Phaeobacter spp. and Silicibacter strain TM1040,
which produced brown pigment and had antibacterial activity
when grown under shaking conditions. For all tested strains,
production of TDA correlated with pigment formation and
antibacterial activity (Fig. 2).
DISCUSSION
Roseobacter clade strains capable of in vitro inhibition of the
fish-pathogenic bacterium V. anguillarum were found in many
sites of a Danish turbot larval farm. In fact, these bacteria
strongly dominated the antagonistic culturable microbiota (51
out of 54 isolates). Roseobacter spp. have been isolated from a
Spanish turbot larval unit (29) and from scallop larval cultures
(43), and Brunvold et al. (10) detected a band using denaturing
gradient gel electrophoresis with sequence homology to a Ro-
seobacter sp. strain from a cod hatchery. This, collectively,
suggests that Roseobacter clade members are common in this
type of environment. We did, like Hjelm et al. (29), also iden-
tify antagonistic Vibrio spp. from the turbot larval rearing unit;
however, these were not further characterized, as they are
likely pathogenic for the turbot (28).
Roseobacter clade strains are often associated with surface
colonization in the marine environment (12, 13) and were
isolated predominantly from surfaces in a Spanish turbot farm
(29). However, in the present study of the Danish turbot farm,
they were equally prevalent in the tank water, and they have
indeed also been isolated as pelagic bacteria in marine envi-
ronments (11, 40). Roseobacter clade strains are often associ-
ated with algal blooms in marine environments and can ac-
count for as much as 50% of the bacterial rRNA genes (1, 11,
22). In concordance with this niche preference, we isolated
several strains from the algal cultures. This particular associa-
tion may render the algae an interesting vector for supplying
the probiotic culture to the fish larval rearing process.
TABLE 3. Abilities of Phaeobacter spp. and Ruegeria spp. to inhibit
17 isolates from a Danish turbot larval farme
Identification of isolates
from samplea
Grading of the size of inhibition
zone in spot assay forb:
Phaeobacter spp.
(42 strains)
Ruegeria spp.
(9 strains)
Water, indoor fish tank
Halomonas sp./Cobetia marinac 3.0  0.0 1.0  0.0
Halomonas sp./Cobetia marina 3.0  0.0 1.6  0.5
Micrococcus sp. 3.0  0.2 2.9  0.3
Halomonas sp./Cobetia marina 3.0  0.0 0.7  0.5
Water, outdoor tank with
phytoplankton and
zooplankton
Pseudomonas sp. 3.0  0.0 0.9  0.8
Pseudomonas sp. 3.0  0.2 0.4  0.9
Pseudoalteromonas sp. 2.0  0.5 0.0  0.0
Water, indoor fish tank
Pseudoalteromonas sp. 3.0  0.0 2.0  0.9
Micrococcus sp. 2.9  0.3 2.4  0.5
Marinomonas sp. 3.0  0.0 2.3  1.0
Surface, indoor fish tank
Rhodococcus sp. 1.0  0.0 0.0  0.0
Surface, outdoor tank with
phytoplankton and
zooplankton
Micrococcus sp. 3.0  0.0 3.0  0.0
Surface, indoor fish tank
Olleya marilimosa 2.9  0.3 2.1  0.9
Unidentifiedd 2.6  0.5 3.0  0.0
Kordia algicida 3.0  0.2 2.0  0.5
Pseudoalteromonas sp. 2.8  0.7 2.4  0.7
Micrococcus sp. 2.7  0.7 2.1  0.9
Diseased rainbow trout
(Oncorhyncus mykiss)
Vibrio anguillarum 90-11-287 3.0  0.3 2.7  0.7
a Isolates were identified by biochemical tests (Gram stain, catalase and oxi-
dase tests, ability to metabolize glucose, reaction on TCBS plates, sensitivity/
resistance to vibriostatic agent 0129), microscopy (motility and shape), and
BLASTN searching of 16S rRNA gene sequences in the NCBI database.
b Grades (0 to 3) indicate the size of the clearing zone around the spot of
colony mass: 0, no zone; 1, 0.5-mm zone; 2, 0.5- to 2-mm zone; 3, 2-mm zone.
Values are averages and standard deviations of 42 Phaeobacter sp. and nine
Ruegeria sp. strains, respectively.
c Cobetia marina (reclassified from Halomonas marina 	3
) and Halomonas sp.
both belong to the Halomonadaceae family.
d Not possible to identify based on the biochemical tests, and BLASTN search
gave low identities to other known species (96%).
e Target bacteria were seeded in agar, and Phaeobacter spp. or Ruegeria spp.
were added on top in a spot assay.
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Comparing 989 bases of the 16S rRNA gene revealed three
clusters among the Danish and Spanish turbot-rearing farm
isolates. Strains similar to P. gallaeciensis BS107 (type strain)
dominated among the indoor isolates, whereas outdoor strains
were similar to P. inhibens T5 (type strain), and all isolates
from algal cultures were similar to type strains R. mobilis
MBIC01146 and R. pelagia HTCC2662. The two latter type
strains are identical on the 16S rRNA level. This indicates that
different species of the Roseobacter clade colonize specific
niches in the Danish rearing unit. All four species from the
Roseobacter clade are very common in marine environments
(11), and as they are easily culturable (6, 32, 38, 43), it is not
surprising to find them in a nutrient-rich environment favoring
fast-growing heterotrophic organisms. The 16S rRNA gene is
very useful as a phylogenetic comparative gene for a number of
genera and species; however, it may not be the optimal differ-
entiating molecule in some genera (14, 49). We considered
that the Roseobacter clade species could, in principle, be diffi-
cult to differentiate based on 16S rRNA genes and therefore
chose to compare the strains using the gyrB gene also, which
has been used successfully to discriminate between genera and
species with closely related 16S rRNA gene sequences (19, 26,
42, 53). In this study, the gyrB gene supported the finding of the
clusters obtained with 16S rRNA gene sequences, but at the
same time it gave a greater evolutionary distance between
the Danish and Spanish strains. To our knowledge, this is the
first time that the gyrB gene has been used for phylogenetic
analysis of Roseobacter clade members.
Subtyping the Danish Roseobacter clade strains using RAPD
with two primers revealed types other than those found in the
Spanish turbot larval farm (29). The two turbot farms have
different water sources (Limfjorden, a fiord in Denmark, ver-
sus the Atlantic Ocean off the Galician coast). Also, specific
subtypes may have preferences for special niches or may have
been introduced at random and remained. This is indicated by
the fact that even though the same water source was used in
the Danish turbot larval farm for inside and outside produc-
tion, only one out of 14 RAPD types was found at both sites.
The diversity in terms of subtypes was much lower in the
indoor production than in the outside production sites. A sim-
ilar phenomenon has been reported for the human-pathogenic
bacterium Listeria monocytogenes (27), which is an environ-
mental bacterium capable of colonizing fish-processing units.
This could be because the outdoor production is an open
FIG. 2. Attachment (a), production of pigment (b), production of
TDA (c), and ability to inhibit Vibrio anguillarum 90-11-287 in well
diffusion assay (d) of Roseobacter clade strains and Vibrio anguillarum
90-11-287 grown under shaking (200 rpm) (black bars) or stagnant (0
rpm) (gray bars) conditions. The attachment experiment was con-
ducted in duplicate, and error bars represent 1 standard deviation.
When measuring TDA, the HPLC-tandem mass spectrometry peak
area from the m/z 213 to 151 transition was used. In the well diffusion
assay, the diameter of the well itself has been subtracted from the
diameter of the inhibition zone.
FIG. 3. Cell morphology of and pigment formation by Roseobacter
clade strains grown in MB under static (0 rpm) (a, c, and e) or shaking
(200 rpm) (b, d, and f) conditions. The Danish Phaeobacter sp. strain
M23-3.1 (a and b), the Spanish Phaeobacter sp. strain 27-4 (c and d),
and the Danish Ruegeria sp. strain M43-2.3 (e and f) are shown.
Microscopy pictures are from phase-contrast microscopy at 1,000
magnification. Bars, 10 m.
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production form and thereby more easily influenced by the
surrounding environment than is the indoor production.
The Phaeobacter spp. and Ruegeria spp. isolated due to their
antimicrobial activity against V. anguillarum also inhibited bac-
terial strains randomly isolated from surfaces and water from
fish tanks in the turbot farm. This is in agreement with the
other studies, as alphaproteobacteria can inhibit different ma-
rine bacteria (24, 33), and Phaeobacter spp. inhibit organisms
as diverse as flavobacteria, Acinetobacter, vibrios, Pseodoaltero-
monas, Alteromonas, Bacillus, and Halomonas (5, 6, 8, 9, 28,
41). Hence, one should be aware that if such bacteria are
deliberately added as probiotic organisms, they may not just
inhibit the pathogenic agents but also alter the general micro-
biota. Therefore, careful supervision of the changes in micro-
biota upon probiotic additions is required.
Phaeobacter spp. appeared more inhibitory than Ruegeria
spp.; however, the two species produced TDA in similar
amounts when grown in stagnant broth cultures (Fig. 2c). We
therefore speculate that Phaeobacter spp. may produce inhib-
itory compounds other than TDA and that these act as anti-
microbials themselves or act synergistically with TDA. The
antagonistic activity of Phaeobacter spp. and Ruegeria spp. is
likely to be an important factor explaining their dominance in
several niches, and indeed they outcompete other marine or-
ganisms such as Pseudoalteromonas tunicata in competition
experiments (41).
The ability of all the Roseobacter clade strains tested to
inhibit V. anguillarum co-occurred with their production of
brown pigment and was independent of the origin of the iso-
lates. A similar coupling has been reported for P. inhibens T5,
Phaeobacter strain 27-4, and Silicibacter strain TM1040 (6, 8,
9). While the inhibitory compound TDA is not the pigment
itself, the coupling between these two phenotypes has also
been demonstrated by transposon mutagenesis creating non-
inhibitory mutants in a Phaeobacter strain and a Silicibacter
strain (20). The production of pigment and antibacterial activ-
ity was influenced by growth conditions; however, this varied
with species, as the Ruegeria spp. behaved like Phaeobacter
strain 27-4 (9), producing pigment and showing antimicrobial
activity only when grown under stagnant conditions. In con-
trast, Phaeobacter spp. from the Danish turbot larval farm
expressed these phenotypes after both stagnant and aerated
growth. This is interesting from an application point of view, as
only a few sites in a fish tank will be stagnant, and hence, the
Phaeobacter spp. isolated in the present study may hold greater
promise as probiotic organisms than Phaeobacter strain 27-4. It
must be determined if the Danish Phaeobacter strains are ca-
pable of disease suppression in vivo as has been documented
for strain 27-4 (39). As seen in this study, strains with 100%
similarity in the 16S rRNA gene sequences do not necessarily
express phenotypes in the same pattern. The same phenome-
non was observed by Grossart et al. (24), as isolates showed
different inhibitory activities against marine bacteria. Also,
Silicibacter strains (Silicibacter strain TM1040 and Silicibacter
pomeroyi strain DSS-3) vary in how the culture conditions
influence pigment production and antimicrobial activity (8). In
the present study, the production of TDA, pigment, and anti-
microbial activity co-occurred for a subset of 12 Roseobacter
clade strains (eight of Phaeobacter spp., three of Ruegeria spp.,
and one of Silicibacter sp.). TDA has been detected from
Phaeobacter spp. and Silicibacter strain TM1040 (6, 9, 20), and
to the best of our knowledge the present study is the first
report of TDA production by R. mobilis/R. pelagia strains.
A prominent characteristic of Phaeobacter and some other
Roseobacter clade strains is their ability to grow as rosettes (8,
9), and this mode of growth appears to enhance the surface
attachment ability of organisms. Also, the strains isolated in
the present study grew as rosettes, and this did correlate, for
Ruegeria, with their attachment capability.
In conclusion, Phaeobacter spp. and Ruegeria spp. with anti-
bacterial activity colonized different units in the Danish turbot
larval farm. We suggest that members of the Roseobacter clade
are common colonizers of marine larval rearing units. This
makes the clade a suitable candidate as a universal marine fish
larval probiotic bacterium. In particular the Danish strains of
Phaeobacter spp. are of applied interest as their antibacterial
activity and TDA production occurred under several types of
growth conditions. However, the true probiotic potential will
have to be further evaluated in in vitro and challenge trials.
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ABSTRACT 1 
The antibacterial compound tropodithietic acid (TDA) is produced by bacteria of the marine 2 
Roseobacter clade and is thought to explain the fish probiotic properties of some roseobacters. The 3 
aim of the present study was to determine the antibacterial spectrum of TDA and the likelihood of 4 
resistance development. TDA was effective against a range of human pathogenic bacteria including 5 
strains resistant to conventional antibiotics. The MICs of TDA were higher for Gram negative 6 
bacteria than Gram positive bacteria.  TDA was bactericidal against Salmonella enterica serovar 7 
Typhimurium SL1344 and Staphylococcus aureus NCTC 12493 and killed both growing and non-8 
growing cells. Several experimental approaches were used to select mutants resistant to TDA or 9 
sub-populations of strains with enhanced tolerance to TDA. No approach (single exposures to TDA 10 
administered via different methods, screening of a Tn-library for resistant mutants or prolonged 11 
exposure to incremental concentrations of TDA) resulted in resistant or tolerant strains. After more 12 
than 300 generations exposed to sub-MIC and MIC concentrations of TDA, strains tolerant to 13 
2xMIC of TDA for wildtype strains were selected but the tolerance disappeared after one passage in 14 
medium without TDA. S. Typhimurium mutants with non-functional efflux pump and porin genes 15 
had the same TDA susceptibility as wildtype strains suggesting that efflux pumps and porins are not 16 
involved in innate tolerance to TDA. TDA is a promising broad spectrum antimicrobial in part due 17 
to the fact that enhanced tolerance is difficult to gain and that the TDA tolerant phenotype appears 18 
to only confer low level resistance and is very unstable. 19 
 20 
Words:  253 21 
22 
3 
 
INTRODUCTION 1 
 2 
The Roseobacter clade, which belongs to the α-proteobacteria, constitute a major part of oceanic 3 
bacterioplankton communities (6,17,46) and many Roseobacter clade strains are easily culturable 4 
(3,20,41).  The success of the Roseobacter clade bacteria may be explained by several factors one 5 
of which is their production of secondary metabolites that may give them a competitive advantage 6 
over other species (19,28,31). This includes the antibacterial compound tropodithietic acid (TDA) 7 
which is produced by several Roseobacter species such as Phaeobacter gallaeciensis, Phaeobacter 8 
inhibens and Ruegeria mobilis (3,5,41). 9 
Ph. gallaciencis and R. mobilis are of great interest in the aquaculture sector for use as 10 
probiotics as they kill or inhibit growth of several fish pathogenic bacteria and they improve 11 
survival of fish larvae in challenge trials (14,22,40). The killing or inhibitory effect appears related 12 
to TDA production (3,22,42). In fact, D’Alvise et al. (2010) showed that the fish pathogenic 13 
bacterium Vibrio anguillarum strain 90-11-287 was only killed by a TDA producing wild type of 14 
Phaeobacter strain 27-4 and not by a mutant deficient in TDA production (13).  15 
The ability of TDA to inhibit several bacteria that are pathogenic to fish and the 16 
possible use of TDA producing bacteria as probiotics in aquaculture raises a number of issues and 17 
questions, and some are addressed in the present study. TDA has antibacterial action against 18 
bacteria outside of the marine or aquatic environment including human pathogenic bacteria 19 
(3,27,49) and could also be of interest as an antibacterial outside the aquaculture sector. However, a 20 
wide spread use of TDA could be potentially detrimental if resistance and subsequent cross-21 
resistance to other agents develops, as it has been the case for the majority of drugs discovered so 22 
far (11). 23 
4 
 
TDA is a disulfide tropolone (8) and it exists in a tautomeric form with thiotropocin 1 
(21). Thiotropocin (or tropodithietic acid) was first isolated from a soil bacterium identified as a 2 
Pseudomonas (8,27) and in addition to Roseobacter-clade bacteria, the compound has also been 3 
isolated from marine Caulobacter spp. and Pseudovibrio strains (15,25). It is antibacterial against 4 
several bacteria including Escherichia coli and Pseudomonas aeruginosa (3,27,49) and is also 5 
inhibitory against some mammalian cells (26).  Tropolones with other side groups than a disulfide 6 
are also known to be antibacterial (33,34) and display antifungal and antiviral activities (7,27). 7 
Bacteria have evolved resistance to virtually all antibiotics introduced into clinical 8 
practice (11) leading to treatment failure of infections of both animals and humans. The purpose of 9 
the present study was to investigate the potential for TDA exposure to select for mutants resistant to 10 
TDA and other agents and to determine mechanisms of resistance to TDA. 11 
 12 
MATERIALS AND METHODS 13 
 14 
Bacterial strains and growth media. The strains used in this study are listed in Table 1. All strains 15 
were grown on LB agar (Oxoid CM1021, Basingstoke, UK) or in LB broth (Oxoid CM1018) at 16 
37°C except for the strains Phaeobacter 27-4, Phaeobacter JBB1001 and V. anguillarum 90-11-17 
287, which were cultured on marine agar 2216 (MA; Difco, BD, Sparks, MD) or in marine broth 18 
2216 (MB; Difco) at 25°. Unless otherwise stated, all strains were incubated for one day except for 19 
Phaeobacter 27-4 which were incubated for two to three days. The strains were either stored on 20 
ProtectTM beads or in a freeze medium (30.0 g Tryptone Soya Broth (Oxoid CM129B), 5.0 g 21 
glucose, 20.0 g skimmed milk powder, 40.0 g glycerol, 1000 ml H2O) at -80°C. 22 
 23 
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Purification of TDA. Phaeobacter 27-4 was grown in 1.5 l MB for four to five days at 25°C at 1 
stagnant conditions. The culture was extracted twice with an equal volume ethyl acetate containing 2 
1 % formic acid and shaken for 10 min in a separation funnel. After phase separation the upper 3 
phase was filtered through anhydrous Na2SO4 (~100 g per L ethyl acetate) and evaporate in vacuo. 4 
Extract from 1.5 l culture was then redissolved in 10 ml 15% acetonitrile and loaded onto a 1 g 5 
Strata-XC column (Phenomenex, Torrance, CA) which was washed with 20 ml 15% acetonitrile 6 
and eluted with 10 ml 70% acetonitrile, which was evaporated using a stream of N2. 7 
 8 
Purity of TDA was verified by LC-UV-HR-MS analysis as described previously (5) as well as 9 
UHPLC-UV/VIS analysis which was perform formed on a RSLC Ultimate 3000 system (Dionex, 10 
Sunnyvale, CA) using a 150 mm × 2 mm i.d., 2.6 µm Kinetex C18 column (Phenomenex), running 11 
at 800 µl/min and 60°C using a binary linear solvent system of water (A) and acetonitrile (B) (both 12 
buffered with 50 µl/l trifluoroacetic acid). The gradient program was: t=0, 15% B; t= 0.5 min 25% 13 
B; t= 6 min 65% B, and t=7 100% B, keeping this for 1 minutes, then reverting to 15% in 1 min. 14 
 15 
Antimicrobial activity of TDA. The minimum inhibitory concentration (MIC) of TDA against a 16 
range of bacteria were determined by the microbroth dilution method (1,2). Semi-purified TDA (see 17 
above) was diluted in 50% ethanol and two-fold dilutions of this TDA stock solution (2530 mg/l) 18 
prepared in microtiter plates. After inoculation with approximately 105 cfu/ml, the human 19 
pathogenic bacteria were incubated at 37°C for 24 h and the marine bacteria at 25°C for 2 days 20 
(Table 1). Growth was determined visually. All MIC determinations were repeated two times in 21 
independent experiments.  To determine if porins or efflux pumps were involved in innate tolerance 22 
to TDA, MIC values of TDA against mutants of Salmonella enterica serovar Typhimurium 23 
(hereafter referred to as S. Typhimurium) with disruptions in the relevant genes (see Table 1) were 24 
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determined as described above.  The MIC of TDA in agar was also determined for S. Typhimurium 1 
SL1344, E. coli NCTC 10538, P. aeruginosa NCTC 10662 and Staphylococcus aureus 12493.  2 
Two fold dilutions of TDA stock solution were incorporated into LB agar (1,2). Cultures were 3 
diluted and 104 cfu spotted onto the agar. Results (growth or no growth) were read after 24 4 
incubation at 37°C. 5 
 6 
Effect of TDA upon bacterial growth. To determine the killing kinetics of TDA, S. Typhimurium 7 
SL1344 and S. aureus NCTC 12493 were grown in LB at 37°C for one day (300 rpm) and 8 
inoculated to 106 cfu/ml in either LB or phosphate buffered saline (PBS) or LB or PBS containing 9 
TDA at concentrations of MIC, ½MIC or ¼MIC. The strains were incubated at 37°C (rpm 300) and 10 
numbers of bacteria determined by plate count at appropriate time points. The experiment was 11 
carried out in duplicate. 12 
 13 
Selection of TDA resistant mutants.  Four different experimental approaches were used to select 14 
TDA resistant mutants. All methods included a single exposure to TDA administered via different 15 
methods.  16 
Exposure to 2xMIC of TDA on agar. Overnight cultures of S. Typhimurium SL1344, 17 
E. coli NCTC 10538, P. aeruginosa NCTC 10662 and S. aureus NCTC 12493 were diluted or 18 
concentrated to give a range of inocula of 105-109 cfu/ml (38). 100 µl of each suspension were 19 
spread onto LB agar containing 2x the MIC of TDA for each strain. Plates were checked every day 20 
for three days for appearance of TDA-resistant colonies. Colonies which arose were retained and 21 
TDA MIC values were determined. 22 
Exposure to MIC or 2xMIC of TDA in broth. Cultures of all strains (apart from the 23 
Salmonella mutants with gene disruptions) were inoculated (107 and 108 cfu/ml) into liquid media 24 
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containing either MIC or 2xMIC of TDA in microtiter trays. After incubation for one (human 1 
pathogens) or two (marine strains) days, a drop of liquid culture was plated on LB or MA plates and 2 
any colonies arising were retained. The MIC of TDA against these colonies was determined as 3 
described above.   4 
TDA diffusion mutant selection. Cultures of S. Typhimurium SL1344, P. aeruginosa 5 
NCTC 10662, E. coli NCTC 10538, S. aureus NCTC 12493 and V. anguillarum 90-11-287 were 6 
diluted in PBS to approximately 105, 106, 107 and 108 cfu/ml were plated onto agar plates. Paper 7 
disks or filter paper in different patterns were placed on the bacterial lawns and TDA stock solution 8 
(2500 mg/l) pipetted onto the disks or paper.  Wells were also drilled into the agar and 70 µl of 9 
TDA stock solution was added. Plates were incubated for 1 (human pathogens) or 2 (V. anguillarum 10 
90-11-287) days and observed for appearance of colonies within the clearing zone formed by 11 
diffusion of TDA into the agar. Colonies were isolated, retained and the MIC of TDA determined. 12 
TDA resistant Tn5-mutants. A random transposon insertion library in S. 13 
Typhimurium SL1344 based on the Tn5 and Mu transposon (9) were screened for mutants with 14 
increased TDA tolerance.  Approximately 104 insertion mutants were screened for the ability to 15 
grow in TDA (2xMIC) and kanamycin (25 mg/l).  Culture grown without TDA served as a control. 16 
After incubation at 37°C for one day, growth was observed visually and cultures were plated onto 17 
LB agar plates. 18 
 19 
Selection of TDA tolerant strains. Three approaches were used to select sub-populations of strains 20 
with elevated tolerance to TDA. 21 
Exposure to ½MIC to 2xMIC of TDA. Cultures (Table 1 strains apart from the 22 
Salmonella mutants with gene disruptions) were inoculated (105 cfu/ml) into medium containing 23 
½MIC of TDA and after incubation overnight 20 µl of the cultures were inoculated into fresh broth 24 
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containing the MIC of TDA (200 µl) incubated again and the following day 20 µl of culture was 1 
inoculated into fresh broth containing 2xMIC of TDA. Experiment was conducted in triplicates. 2 
Exposure to ½MIC of TDA. S. Typhimurium SL1344, P. aeruginosa NCTC 10662, 3 
E. coli NCTC 10538, S. aureus NCTC 12493, V. anguillarum 90-11-287 and Phaeobacter 27-4 4 
were re-inoculated (30 µl) six times in medium (2970 µl) containing ½MIC of TDA. These 5 
transfers equaled 42-48 generations. Human pathogenic bacteria were incubated for one day at 6 
37ºC, whereas marine bacteria were incubated for two day at 25ºC. 7 
Exposure to 1/16MIC to MIC of TDA. S. Typhimurium SL1344 was re-inoculated 8 
(10 µl) five times into 990 µl LB and then 40 times into gradually increasing concentrations of 9 
TDA (from 1/16MIC to MIC), which in total equals 315-360 generations. The experiment was 10 
carried out with triplicate lineages.  A control in duplicate lineages was also re-inoculated (10 µl 11 
into 990 µl LB) 45 times (315-360 generations), but without TDA.  All cultures were inoculated 12 
once per day and incubated at 37°C. At the end of all three adaptive approaches, MIC of TDA were 13 
determined both for cultures exposed to TDA but also for control cultures. 14 
 15 
RESULTS 16 
 17 
Antimicrobial activity of TDA. TDA inhibited the growth of both Gram negative and Gram 18 
positive bacteria in broth; the latter group (80 – 155 mg/l) was generally more susceptible to TDA 19 
than the Gram-negative bacteria (625 – 1250 mg/l) (Table 1). V. anguillarum 90-11-287, 20 
Phaeobacter 27-4 and Morganella morganii NCTC 235 were exceptions, as they were inhibited by 21 
concentrations similar to the Gram positive bacteria even though they are Gram negative. The 22 
solvent of TDA (50% ethanol) did not inhibit the bacteria in the dilutions used. TDA is degraded at 23 
high temperatures (5) so as a control, the values were also determined for TDA that had been 24 
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incubated at 37°C or 25°C prior to inoculation. This gave the same MIC values as when inoculating 1 
straight away (data not shown) and hence, degradation of TDA did not take place during our assay. 2 
None of the porin or efflux pump mutants of S. Typhimurium had major altered tolerance to TDA 3 
compared with their parental strains. 4 
 5 
Effect of TDA upon bacterial growth. TDA is a bactericidal compound as both S. Typhimurium 6 
SL1344 and S. aureus NCTC 12493 were killed by the MIC value in both LB (Figure 1A and 1C) 7 
and in PBS (Figure 1B and 1D). The reduction in cell numbers was greater for the S. aureus (≥ log 8 
5 reduction) compared with the Gram negative bacterium (log 3 reduction) in LB broth.  At ½MIC 9 
and ¼MIC killing of both S. Typhimurium SL1344 and S. aureus NCTC 12493 in PBS was seen. A 10 
dose-response kinetic relationship was observed for both the growth media and the buffer. As the 11 
concentration of TDA increased, the faster the bacteria were killed or growth of the bacteria was 12 
inhibited for longer. 13 
 14 
Selection of TDA resistant mutants. None of the experimental approaches used in this study 15 
resulted in stable TDA resistant mutants.  Although  S. Typhimurium SL1344, E. coli NCTC 10538, 16 
P. aeruginosa NCTC 10662 and S. aureus NCTC 12493 all gave rise to colonies on agar containing 17 
2xMIC of TDA, the MIC of TDA was the same as prior to TDA exposure after one inoculation in 18 
fresh media. Independent of inoculation level (107 or 108 cfu/ml), none of the strains survived 19 
exposure to 2xMIC of TDA in broth (except S. aureus NCTC 8532).  When inoculating in broth 20 
containing the MIC of TDA, 10 of 18 strains survived (S. Typhimurium SL1344, ATCC 14028s 21 
and L3, Enterobacter cloacae NCTC 10005, Serratia marcescens NCTC 2847, P. aeruginosa 22 
NCTC 10662, Klebsiella pneumonia NCTC 10896, M. morganii NCTC 235, S. aureus NCTC 8532, 23 
Enterococcus faecalis NCTC 775 and NCTC 7171 and Listeria monocytogenes NC12427). 24 
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However, after one passage in fresh medium, no altered MIC values were observed when compared 1 
to the original strains.  In experiments using diffusion of TDA in to agar, no colonies appeared 2 
inside the clearing zones for any of the five strains tested in any of the three diffusion methods used. 3 
A transposon insertion library in S. Typhimurium SL1344 was exposed to 2xMIC in liquid medium 4 
and plated on agar plates.  However, no colonies with decreased susceptibility to TDA appeared. 5 
 6 
Selection of TDA tolerant strains. Two of the three adaptation experiments resulted in “variants” 7 
that tolerated slightly elevated TDA concentrations.  However, the phenotype was not stable after 8 
passage in drug free media.  In the first adaptation experiment, concentrations of TDA were 9 
increased from ½MIC to MIC and to 2xMIC, nine of the 18 strains (S. Typhimurium L10, E. 10 
cloacae NCTC 10005, S. marcescens NCTC 2847, P. aeruginosa NCTC 10662, K. pneumonia 11 
NCTC 10896 and NCTC 9633, E. coli NCTC 10538, V. anguillarum 90-11-287 and L. 12 
monocytogenes NC12427) were able to survive and grow on 2x the MIC of TDA.  However, when 13 
re-tested none of these nine strains had decreased susceptibility to TDA.  In the second adaptation 14 
experiment, where S. Typhimurium SL1344, P. aeruginosa NCTC 10662, E. coli NCTC 10538, S. 15 
aureus NCTC 12493, V. anguillarum 90-11-287 and Phaeobacter 27-4 were exposed to six re-16 
inoculations in ½MIC of TDA, the MIC of TDA required to inhibit the final populations were two-17 
fold higher than for parental strains.  However, after one passage in fresh medium none of the 18 
strains had altered susceptibility to TDA.  In the last experiment, S. Typhimurium SL1344 was 19 
exposed to gradually increasing concentrations of TDA for a prolonged period (40 transfers). The 20 
MIC of TDA was two-fold higher for the final cultures arising in the experiment (all three lineages).  21 
However, after one inoculation in fresh medium, the MIC again reverted to the original wild-type 22 
level. 23 
 24 
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DISCUSSION 1 
It has been previously shown that TDA producing Roseobacter have the ability to inhibit or kill 2 
other marine bacteria (3,13,22,42), and that purified TDA alone has a growth inhibitory effect 3 
against marine bacteria (3). This study shows that pure TDA is a strong antibacterial compound, 4 
effective against all the human pathogenic strains tested including strains resistant to conventional 5 
antibiotics. The tautomeric form of TDA, thiotropocin, produced by Caulobacter and Pseudomonas 6 
strains also inhibited the growth of all tested bacteria (27,49). Both Gram negative and –positive 7 
human pathogens were affected by TDA, however, Gram positive bacteria generally required a 8 
lower concentration for inhibition compared to Gram negatives. This could be due to the different 9 
structures of the cell wall in the two bacterial groups, and the outer membrane in the Gram negative 10 
bacteria could act as a protective barrier against TDA. Treatment of the Gram negative strain S. 11 
Typhimurium SL1344 with 0.5 mM EDTA (this concentration does not affect growth) rendered the 12 
cells more sensitive to TDA, whereas this is not the case for the Gram positive strain S. aureus 13 
NCTC 12493 (data not shown). These data support the hypothesis that the outer membrane of the 14 
cell envelope gives protection to Gram negative bacteria, as EDTA is known to destabilize this 15 
membrane by binding divalent cations (29). 16 
Neither the porin mutants nor efflux pump mutants of S. Typhimurium had elevated 17 
tolerance towards TDA compared to their parental strains. This indicates that perhaps TDA is 18 
neither transported into the bacterial cell through porins nor exported out again through the major 19 
efflux pumps. Keeping in mind that TDA works very well on non-growing cells these results could 20 
collectively indicate that TDA may not have to enter the bacterial cell in order to exert its effect. 21 
Thereby the cell envelope could be the bacterial target for TDA. This theory is supported by results 22 
from a biosensor method, which is based on activation of fluorescence signals (GFP variants) 23 
engineered to report induction of genes responsive to inhibition or perturbation of various core 24 
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metabolic pathways of Salmonella. This method showed that the cell envelope is damaged by TDA 1 
and the peptidoglycan structure might be directly affected (Dirk Bumann, University of Basel, 2 
personal communication).  3 
V. anguillarum 90-11-287 was very sensitive to TDA and inhibited by a MIC value in 4 
the same range as the Gram positive bacteria. The producer strain of TDA (Phaeobacter 27-4) was 5 
isolated specifically due to its antagonistic effect against this strain (22). The Gram negative TDA 6 
producer strain itself is also inhibited by a low TDA concentration and did not, in our assay, display 7 
the expected resistance to TDA.  It is possible that these data were obtained as the conditions used 8 
in the MIC value determination with only two days of incubation did not support production of 9 
TDA by Phaeobacter 27-4. TDA is produced in late exponential phase and requires a large surface-10 
volume ratio (4,5). We hypothesize that only when TDA is produced does the producer organism 11 
express the mechanism(s) by which it become(s) resistant to its own drug. 12 
 TDA was bactericidal against both S. Typhimurium SL1344 and S. aureus 12493, and 13 
the MIC value for each strain was also lethal in rich growth medium (LB). This indicates that the 14 
MIC and the minimum bactericidal concentration (MBC) are the same for TDA as has been 15 
reported for some host defense peptides (18). Bacteria treated with TDA were unable to multiply, 16 
but remained viable for one hour after which the bacteria died. The same phenomenon has been 17 
described for the host defense peptide Plectacin (45). When carrying out killing kinetics in a 18 
nutrient poor medium (PBS), where essentially no cell division occurs, all tested concentrations of 19 
TDA kill the bacteria rapidly. These results suggest that TDA is active against both growing and 20 
non-growing cells. This has been reported for glycan-targeting antibiotics like moenomycin and 21 
teicoplanin (10,50). 22 
 Several different methods for selecting TDA resistant mutants or strains with 23 
tolerance towards TDA were explored in this study. Most of the methods reported in the literature 24 
13 
 
for such a purpose were used.  We did not use the gradient gel method (10), as this technique 1 
requires large volumes of the compound of interest and our available, pure supply of TDA was 2 
limited.  3 
 None of the methods of single exposure to TDA resulted in mutants resistant to TDA.  4 
This could indicate that more than one mutation is needed in order to gain resistance. In this 5 
manner, TDA may resemble ‘dirty drugs’ such as biocides or antimicrobial peptides that have 6 
multiple targets in bacteria and thus require mutations in multiple loci in order to evolve tolerance 7 
(37,43), although biocides are often mixtures and TDA is not. A slow adaptation to gradually 8 
increasing concentrations of the drug has proven to be a successful way of getting stable strains 9 
with enhanced tolerance to an antimicrobial peptide and to biocides (24,32,36,48) but a similar 10 
approach was not successful in this study as S. Typhimurium SL1344 immediately lost the gained 11 
tolerance. Earlier studies showed a gradual deadaptation of the decreased sensitivity to different 12 
biocides  (23,32,44,48) however Sallun & Chen (2008) reported that the tolerance toward the 13 
antimicrobial peptide Cecropin B was abolished after one passage in fresh medium without the 14 
peptide (44) just as found in the present study with TDA. 15 
Tolerance to a drug can, apart from ‘fixed’ mutation, also occur as a response to 16 
environmental stimuli leading to a phenotypic response (30). It is doubtful that true adaptation to 17 
TDA was seen in this study, as the tolerance was only two fold higher greater than non-adapted 18 
cells, whereas in the literature for quaternary ammonium compounds and the antimicrobial peptide 19 
cecropin it is reported as many fold higher (23,32,44). The increased tolerance to TDA seen in this 20 
study could be the result of a phenotypic switch which is rapidly reversed post exposure to TDA. 21 
 Based on the results obtained in this study, we conclude that TDA has a wide 22 
spectrum of activity against pathogenic bacteria.  We also conclude that it is difficult to create 23 
stable strains with tolerance to TDA. We suggest that the compound resembles antimicrobial 24 
14 
 
peptides and biocides with regard to mechanism-of-action as compared to antibiotics. As only a 1 
slight increase in TDA tolerance was observed and any TDA tolerance phenotype was unstable 2 
TDA is an interesting compound for the potential control of bacterial diseases in aquaculture as well 3 
as in other settings. 4 
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Legends to figures  1 
 2 
Figure 1. Killing kinetics of tropodithietic acid (TDA) against Salmonella enterica serovar 3 
Typhimurium strain SL1344 (A and B) and Staphylococcus aureus NCTC 12493 (C and D) in LB 4 
medium (A and C) and in phosphate buffered saline (B and D). The following concentrations of 5 
TDA were used: MIC ( ), ½MIC ( ), ¼MIC ( ) and a growth control containing no TDA ( ). 6 
Counts are mean of duplicates and error bars represent standard deviations. Vertical arrows indicate 7 
detection limit. 8 
 9 
21 
 
Table 1 Bacterial strains used in this study. 1 
Gram Species Strain Genotype References / Sources 
Negative Salmonella Typhimurium SL1344 Wildtype Wray & Sojka, 1978 (51) 
 Salmonella Typhimurium SL1344 ompF::aph Coldham et al., 2010 (12) 
 Salmonella Typhimurium SL1344 ompC::aph Coldham et al., 2010 (12) 
 Salmonella Typhimurium ATCC 14028s Wildtype ATCC a 
 Salmonella Typhimurium ATCC 14028s ∆tolC::CmR Nishino et al., 2006 (35) 
 Salmonella Typhimurium ATCC 14028s ∆acrB::KmR Nishino et al., 2006 (35) 
 Salmonella Typhimurium ATCC 14028s ∆acrAB::CmR Nishino et al., 2006 (35) 
 Salmonella Typhimurium ATCC 14028s ∆acrD::CmR Nishino et al., 2006 (35) 
 Salmonella Typhimurium ATCC 14028s ∆acrEF::CmR Nishino et al., 2006 (35) 
 Salmonella Typhimurium ATCC 14028s ∆mdtABC::CmR Nishino et al., 2006 (35) 
 Salmonella Typhimurium ATCC 14028s ∆mdsABC::CmR Nishino et al., 2006 (35) 
 Salmonella Typhimurium ATCC 14028s ∆ermAB::CmR Nishino et al., 2006 (35) 
 Salmonella Typhimurium ATCC 14028s ∆mdfA::CmR Nishino et al., 2006 (35) 
 Salmonella Typhimurium ATCC 14028s ∆mdtK::CmR Nishino et al., 2006 (35) 
 Salmonella Typhimurium ATCC 14028s ∆macAB::CmR Nishino et al., 2006 (35) 
 Salmonella Typhimurium L3 Human  pre-therapy clinical isolate Piddock et al., 2000 (39) 
 Salmonella Typhimurium L10 Human  post-therapy clinical isolate, acrAB+++ Piddock et al., 2000 (39) 
 Enterobacter cloacae NCTC 10005  NCTC b 
 Serratia marcescens NCTC 2847  NCTC b 
 Klebsiella pneumoniae NCTC 10896  NCTC b 
 Klebsiella pneumoniae NCTC 9633  NCTC b 
 Escherichia coli NCTC 10538, K12  NCTC b 
 Morganella morganii NCTC 235  NCTC b 
 Pseudomonas aeruginosa NCTC 10662  NCTC b 
 Vibrio anguillarum 90-11-287 (from rainbow trout)  Skov et al., 1995 (47) 
 Phaeobacter ssp. 27-4 (from Spanish turbot unit) Wildtype Hjelm et al., 2004 (22) 
 Phaeobacter ssp. JBB1001 tdaB::EZ-Tn5,Kan Geng et al., 2008 (16) 
Positive Staphylococcus aureus NCTC 8532 (MSSA)  NCTC b 
 Staphylococcus aureus NCTC 12493 (MRSA)  NCTC b 
 Enterococcus faecalis NCTC 775  NCTC b 
 Enterococcus faecalis NCTC 7171  NCTC b 
 Listeria monocytogenes NC12427  NCTC b 
a
 ATCC: American Type Culture Collection 2 
b
 NCTC: National Collection of Type Cultures (HPA, Colindale, London, UK)3 
22 
 
Table 2 MIC values (mg/l) of tropodithietic acid determined in LB broth. MICs were determined in 1 
two independent experiments and if all gave the same value, this is stated in the table. For some 2 
strains, MIC varied a factor of two between experiments as indicated. 3 
 4 
Gram Species Strain MIC (mg/l) 
Negative Salmonella Typhimurium SL1344 (wildtype) 625 
 Salmonella Typhimurium SL1344 (ompF::aph) 625 
 Salmonella Typhimurium SL1344 (ompC::aph) 625 
 Salmonella Typhimurium ATCC 14028s (wildtype) 625 
 Salmonella Typhimurium ATCC 14028s (∆tolC::CmR) 625 - 1250 
 Salmonella Typhimurium ATCC 14028s (∆acrB::KmR) 625 - 1250 
 Salmonella Typhimurium ATCC 14028s (∆acrAB::CmR) 625 - 1250 
 Salmonella Typhimurium ATCC 14028s (∆acrD::CmR) 625 - 1250 
 Salmonella Typhimurium ATCC 14028s (∆acrEF::CmR) 625 - 1250 
 Salmonella Typhimurium ATCC 14028s (∆mdtABC::CmR) 625 - 1250 
 Salmonella Typhimurium ATCC 14028s (∆mdsABC::CmR) 625 - 1250 
 Salmonella Typhimurium ATCC 14028s (∆ermAB::CmR) 625 
 Salmonella Typhimurium ATCC 14028s (∆mdfA::CmR) 625 
 Salmonella Typhimurium ATCC 14028s (∆mdtK::CmR) 625 - 1250 
 Salmonella Typhimurium ATCC 14028s (∆macAB::CmR) 625 
 Salmonella Typhimurium L3 (Human  pre-therapy clinical isolate) 625 - 1250 
 Salmonella Typhimurium L10 (Human  post-therapy clinical isolate, acrAB+++) 625 - 1250 
 Enterobacter cloacae NCTC 10005 625 - 1250 
 Serratia marcescens NCTC 2847 625 - 1250 
 Klebsiella pneumoniae NCTC 10896 625 - 1250 
 Klebsiella pneumoniae NCTC 9633 625 
 Escherichia coli NCTC 10538 (K12) 155  - 625 
 Morganella morganii NCTC 235 155 
 Pseudomonas aeruginosa NCTC 10662 625 
 Vibrio anguillarum 90-11-287 (from rainbow trout) 40 - 80 
 Phaeobacter ssp. 27-4 (from Spanish turbot unit) (wildtype) 310 
 Phaeobacter ssp. JBB1001 (tdaB::EZ-Tn5,Kan) 155 
Positive Staphylococcus aureus NCTC 8532 (MSSA) 155 
 Staphylococcus aureus NCTC 12493 (MRSA) 155 
 Enterococcus faecalis NCTC 775 80 
 Enterococcus faecalis NCTC 7171 80 
 Listeria monocytogenes NC12427 80 
 5 
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